Nascop Indicators Manual

NASCOP
INDICATORS MANUAL
1
Table of Contents
Foreword
Acknowledgement
Acronyms
Introduction
How to use this manual
Appendix 1 – Indicator Reference Sheet
Appendix 2 – Indicator Description Templates
References
2
("I FOREWORD
The National AIDS Control Council (NACC) and its partners developed the Kenya National HIV
and AIDS Strategic Plan covering the period 2009110 to 20 12/ 13 in response to new evidence from
the HIV strategic information. A National Monitoring, Evaluation and Research Framework was
also developed in order to establish a well coordinated, hamonized monitoring, evaluation and research
system that provides time,$ and accurate strategic infomation to guide the planning of NIV avtd AIDS national
response toward achievement of KNASP 111 objectives. While NACC has the overall mandate of
stewardship for KNASP 111, the National M&E Framework will rely on the health sector to report
on 41% of the proposed indicators through the National AIDS and ST1 Control Programme
(NASCOP). Successful implementation of the national M&E framework requires all health sector
implementers to first reach consensus on the agreed indicator definitions, disaggregation, data collection
and reporting procedures, responsibilities and timelines. This will enable the country to measure progress
towards set targets for KNASP m.
This integrated health sector HJY indicators and procedures manual has been developed through an all
inclusive and participatory approach that has cultivated countrywide interest and ownership among
concerned stakeholdas at national and decentrahzed levels. In addition to representing an important
milestone toward operationalizing the KNASP III National M&E Framework, it dis-hes priority
indicators for sectoral and programme level reporting. It is envisaged that a common understanding on the
core indicator set, tools and procedures will be achieved through rapid dissemination to M&E focal persons
w i h the ministries of health and implementing agencies, white structured training w ill ensure compliance
and generate timely, complete and accurate reports under one national M&E system. The govemenr is
committed to mobilizing resources to fadtate the rapid roll out of hdocument to policy makers,
programme managers and service providers at all levels.
t '
Dr. S. K. Sharif
Director of Medical Services Director of Public Health and Sanitation
ACKNOWLEDGEMENT
This document is the result of a highly consultative eight month indicator review and harmonisation
process that was initiated in November 2009. The National AIDS/STD Control Programme
(NASCOP) of the Ministry of Health, as the responsible agency for the health sector HIV-related
indicators, hereby acknowledges the efforts of all institutions and individuals from the government
ministries and agencies, development partners, plus implementing partners at national and
decentralized levels, including the private sector.
We first acknowledge the National AIDS Control Council (NACC) for its leadership in developing
Kenya’s third National HIV and AIDS Strategic Plan (2009/10-2012/13) and the National
Monitoring, Evaluation and Research Framework which provided the basis for NASCOP’s HIV
indicator review. We commend the Division of Health Information Systems (HIS) for aligning
NASCOP’s efforts within the broader health sector indicator review and harmonization process. We
thank the Heads of HIV- related divisions (Division of Leprosy, Tuberculosis and Lung Diseases,
Division of Reproductive Health, Division of Nutrition, Division of Child Health and Division of
Malaria Control) as well as Programmes (National Public Health Laboratory, National HIV
Reference Laboratory, National Blood Transfusion Services) for enabling their M&E focal persons to
participate in the consultative meetings as needed. Special thanks go to NASCOP’s former Head for
Monitoring and Evaluation, Anne Barsigo, for coordinating the initial part of the process, and her
successor Dr. Davies Kimanga for guiding its completion. We also acknowledge other departmental
heads and focal persons at NASCOP for facilitating the thematic technical working group discussions
on indicators, tools and procedures needed for tracking HIV Prevention, Treatment, Care and Support
interventions. Specifically, these include: I Mukui, S Vakil, M Sirengo, M Anyona, R Kamau, P
Mwololo, H Mutiso, M Wachira, and F Ndwiga. Other staff that supported the review include J
Mutiso, N Shiyonga, C Njogu, Z Wagaki, J Wanyungu, L Mwikya, D Kongai, C Wandera and J
Muchase.
We hereby express much appreciation to our implementing partners for their continued support to the
process. Special thanks to Jim Setzer, Paul Chishimba and Saade Abdallah from Health Systems
20/20 who assisted NASCOP and the Division of HIS with planning, implementation and reporting
on the indicator review meetings and also provided direct support in the revision of the indicator
definitions, tools and procedures manuals. We acknowledge M&E focal persons from numerous
implementing partners (including AED, AIDS Relief, AMPATH, AMREF, APHIAs, CWS, EGPAF,
FACES, FHI, Futures Group, ICAP, ICF Macro, Jhpiego, LVCT, Macro, MSF, MSH, NARESA,
Phones 4 Health, PSI, Univ Maryland, Vihda, WRP) for their time and active participation. The
following hospitals also deserve mention for their input to the process: Bomu, Coptic, CPGH, Mater,
Mbagathi District Hospital and The Nairobi Hospital.
We are particularly grateful to the development partners who provided technical and financial support
to ensure the successful completion of the indicator review and harmonization. Specifically to the
United States Government (through USAID and CDC), the United Nations (through WHO,
UNAIDS, WFP)missions and SPEAK. Special thanks to Washington Omwomo, Liz Ojowi, Gilbert
Aluoch, Rex Mpazanje, David Chitate and Yuko Takenaka for their active interest and dedication to
the process.
Finally we thank all those who contributed directly or indirectly to the indicator procedures manual
Dr. Ibrahim Mohamed, Head NASCOP Dr. Nicholas Muraguri, Head NASCOP
Ministry of Medical Services Ministry of Public Health and Sanitation
4
Acronyms
ABC Abstinence, Be Faithful and Condom Use
AIDS Acquired Immune Deficiency Syndrome
ANC Antenatal Clinic
ART Antiretroviral Therapy
ARV Antiretroviral Therapy
HIV Human Immunodeficiency Virus
HMIS Health Management Information System
M&E Monitoring & Evaluation
MOH Ministry of Health
MSM Men who have Sex with Men
MTCT Mother to Child Transmission
NAC National AIDS Council
OVC Orphans and Vulnerable Children
PEPFAR President’s Emergency Plan for AIDS Relief
PCR Polymerase Chain Reaction
PLWHA Persons Living With HIV
PMTCT Prevention of Mother To Child Transmission
STI Sexually Transmitted Infections
CSW Commercial Sex Worker
TB Tuberculosis
UNAIDS Joint United Nations Programme on HIV and AIDS
UNDP United Nations Development Programme
UNESCO United Nations Education Scientific and Cultural Organization
UNFPA United Nations Population Fund
UNGASS United Nations General Assembly Special Session on HIV
UNICEF United Nations International Children’s Fund
USAID United States Agency for International Development
VCT Voluntary Counseling and Testing
WHO World Health Organization
5
Introduction
The Government of Kenya and donors are working to fight many diseases, including HIV/AIDS, and
to make improvements in a number of health areas. As national programs and associated projects to
support these programs grow, accountability for funding and results reported is becoming increasingly
important. These programs and associated projects are setting ambitious goals and objectives and the
achievement of which are measured through monitoring and evaluation (M&E) indicators.
NASCOP and its implementing partners play a key role in Kenya’s HIV/AIDS programs and the
indicators measure the inputs, outputs, outcomes and impacts of its programs. Most of the data for
these indicators are produced by MOH health facilities. In order to ensure quality and comparability
across programs and implementing partners, standardized indicator protocol documentation must
exist for the collection, aggregation, storage and transfer of program data.
This integrated health sector HIV indicators and procedures manual has been developed through an all
inclusive, and participatory approach that cultivated countrywide interest and ownership among concerned
stakeholders at national and decentralized levels. Health sector implementers through a series of meetings
made strides to reach consensus on indicator list, indicator definitions, disaggregation, data collection and
reporting procedures, responsibilities and timelines. This should enable the country to measure progress
towards set targets for KNASP III.
This document is to be used as a companion to the KNASP III and the National M&E Framework
reference documents. This manual should be used to orient staff to the M&E System and their role in
it. It should be used to understand indicators and their definitions, data sources, data flow and
information use. It should also be used to understand.
Purpose
A key component of a strong M&E system is the documentation of the processes related to the
collection, aggregation, storage and transfer of programmatic data. An analysis of an M&E system
will seek to assure that:
• Indicators have clear definitions, data sources with baselines and targets
• There are standard data-collection and reporting forms that are systematically used
• Source documents are kept and made available in accordance with a written policy
• Clear documentation of collection, aggregation, storage and transfer of data exists
• Clearly defined procedures exist to identify and reconcile discrepancies in reports
• Key M&E and data-management staff are identified and have clearly assigned
responsibilities
An Indicator Description Template assures all of these exist and are properly documented. In short,
an Indicator Description Template outlines the what, who, when, where and how of collecting,
aggregating, storing and transferring indicator data. Completing this template not only documents the
standard operating procedures related to data collection and distribution, but also helps identify gaps
in the Monitoring and Evaluation system.
The general purpose of an Indicator Description Template is to:

• Define rationale for selecting indicators, provide definition for indicator, and identify the
plans for data collection, analysis reporting and review.
• Help ensure reliability of indicators as they provide critical information to help different
people repeatedly measure the indicator with the same precision.
• Provide the organization with the means to collect data over time.
6
Indicator Description Template
Please see Appendix 1 for detailed Indicator Description Templates that provide detailed
information on indicator definition, reportable data elements, data sources, data management
guidelines, data collection frequency and interpretation for each indicator.
How to use this Manual
This section gives the outline of the indicator description template used in this manual. This filled-out
indicator description templates follow as Appendix 1 grouped by objectives outlined in KNASP III.
The following describes the fields used in the indicator descriprtions template:
Indicator title: Indicate the title of the indicator being collected. The title is provided by NASCOP
and is typically in line with national and international partners. The definition of the indicator,
including definition of numerator and denominator, and proposed calculations should also be
provided as needed.
Programme Goal: Indicate a statement of the overall mission or purpose(s) of the program.
Codes: The code as used by respective donor and international partners is indicated here for ease of
reference. (KNASP, UNGASS, AOP, WHO, UNICEF, PEPFAR, GFTAM, Other)
Definition of Important Terms: Provide the general definition as well program-specific information
in addition to what has been provided. The definition of important terms must be detailed enough to
ensure individuals involved with data collection for particular indicator fully understand the terms
used in the indicator.
Disaggregation: Into what categories are you disaggregating your units of measure in order to
increase the breadth of understanding of reported results? For example, people can be disaggregated
by gender, target population (e.g., IDUs, sex workers), age group, etc.
Reportable Data Elements: These are coded references to MOH reporting forms and highlight only
the required elements for the particular indicator.
Purpose: The reason for collecting the information; what the indicator attempts to measure.
Data Collection Frequency: The recommended frequency with which the indicator should be
measured.
Data Source: These are measurement tools that are needed to collect the indicator. The source can
also be described as the entity from which the data are obtained. Describe the location and format of
these data for future access and follow-ups as needed.
Data Management Guidelines: The suggested methodology for collecting each indicator and the
level at which it should be measured. This includes the instructions for collecting data, including
references to data sources for both numerator and denominator. The goal of this section is to outline
the process in such detail that will minimize chances of double counting as well as standardize data
collection processes across reporting entities.
Interpretation: This section describes how to use of the results of the indicator. It also highlights the
main strengths and limitations of indicator.
7
<Care and Treatment>
Indicator #: Percentage of PLHIV who know their status and are receiving Cotrimoxazole
HIV03-01 prophylaxis
The goal for KNASP III is to ensure that all HIV positive patients receive CTX
Programme Goal: regardless of their treatment or care status, CD4 level or clinical stage
Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Codes: 1.3.1 - - - - C2.2.D HIV‐CS1 -
Definition of Receiving Cotrimoxazole: Individuals should be considered to be “receiving”

Important Terms: Cotrimoxazole prophylaxis if Cotrimoxazole has been prescribed and obtained by the
patient (at the facility or procured by the patient). This represents only unique
individuals receiving CTX within the reporting period therefore a patient should not be
counted more than once if reporting aggregates covering more than one reporting point.
Eligible for Cotrimoxazole: These are HIV-positive individuals who meet the criteria
for eligibility to commence Cotrimoxale prophylaxis based on the current treatment
guideline. The goal for KNASP III is to ensure that all HIV positive patients receive
CTX regardless of their treatment or care status, CD4 level or clinical stage.
Numerator: Number of adults and children living with HIV enrolled in HIV care and receiving
Cotrimoxazole prophylaxis
Denominator: Number of adults and children living with HIV enrolled in HIV care that are eligible for
Cotrimoxazole prophylaxis based on national guidelines.
Disaggregation: By sex: Male and Female and by age: <15, 15+
Reportable Data Numerator:
Elements: Code
On CTX – Male (<15) HV03-03
On CTX – Male (15+) HV03-04
On CTX – Female (<15) HV03-05
On CTX – Female (15+) HV03-06
Total on CTX (Sum HV03-03...HV03-06) HV03-07
Denominator:
o Non-routine – population-based or the number of HIV-positive individual receiving
HIV care services.
Purpose: Cotrimoxazole prophylaxis is a simple and cost-effective intervention that reduces the
risk of opportunistic infections (OIs) and mortality in HIV-positive children and adults.
Data Collection Data should be collected continuously at the facility level (or community level). Data
Frequency: should be aggregated periodically, i.e. monthly or quarterly for the purposes of program
management and review.
Data Source: Numerator: Primary data collection tools which include Pre-ART and ART registers.
Where electronic databases exist and are up-to-date in routine recording for the
provision of CTX, these can provide and easy and efficient source of data. Pharmacy
records can also be used in conjunction with registers.
Denominator: This is considered in the context of the national policy on CTX and can
be either, Total numbers of HIV-positive individuals in the country or the number of
HIV-positive individuals receiving HIV care services.
Data Management Numerator can be generated by counting the number of HIV-positive individuals
Guidelines: receiving Cotrimoxazole prophylaxis at some point during the reporting period.
Facilities should focus on compiling data for the numerator from patient registers at
facilities.
Denominator: is the total number of individuals receiving HIV care and support
8
services.
Interpretation: This indicator permits monitoring trends in the numbers and proportion of HIV positive
persons receiving CTX prophylaxis.
In addition to tracking the numbers of persons on prophylaxis, this indicator can be
interpreted as a proportion, or measure of coverage, using various denominators as
appropriate. Coverage can be considered using different denominators, for example the
proportion of HIV-positive persons in care (receiving at least one clinical service)
receiving CTX, the proportion of the estimated number of HIV-positive persons in the
country (or region) receiving CTX, or the proportion of HIV-positive individuals who
are eligible for CTX, (according to national guidelines) who are receiving CTX.
This indicator attempts to track progress in scale-up of CTX to HIV-positive individuals
in a country. The indicator does not attempt to capture interruptions in drug availability
or patient adherence to prescribed therapy. The report should be interpreted in the
context of the national policy.
9
Indicator #:
HIV03-02 Number of adults and children with advanced HIV infection newly enrolled on ART
Programme Goal: The goal of this indicator is assesses progress in providing antiretroviral combination
therapy to everyone with advanced HIV infection.

Codes - AOP-29 - - T1.1.D - -
Advanced HIV infection: Advanced HIV/AIDS disease case is defined for surveillance
as: any clinical stage 3 or 4 disease or, where CD4 is available, any clinical stage with
CD4 < 350. This differs from the immunological criteria for initiating ART at CD4 <
200.
Definition of
Newly enrolled on ART: NEW refers to a patient who starts ART at any facility in the
Important Terms:
country or system and is a state defined by an individual’s beginning in a program, it is
expected that the characteristics of new clients are recorded at the time they newly
initiate into a program. Patients are counted as pregnant if they were pregnant at
initiation of ART. Age represents an individual’s age at initiation of therapy.
Numerator: Number of adults and children with advanced HIV infection newly enrolled on ART
Denominator: N/A
Disaggregation: By sex: Male and Female, By age: <1, <15, 15+, and Pregnant women
Numerator:
Code
Start ART – (<1) HV03-08
Start ART – Male (<15) HV03-09
Start ART – Female (<15) HV03-10
Reportable Data Start ART – Male (15+) HV03-11
Elements Start ART – Female (15+) HV03-12
Start ART (Sum HV03-08…HV03-12) HV03-13
Start ART – Pregnant HV03-14
Denominator: None
Measures scale-up of ART program and for pregnant women disaggregation offers a
Purpose:
measure of the linkages between PMTCT and treatment programs.
Data should be collected continuously at the facility level (or community level). Data
Data Collection
should be aggregated periodically, i.e. monthly or quarterly for the purposes of program
Frequency
management and review.
Facility ART registers/databases, program monitoring tools, or drug supply
Data Source
management systems
The numerator can be generated by counting the number of adults and children who
are newly enrolled in ART in the reporting period, in accordance with the national
approved treatment protocol.
Data Management Patients with records that transfer in from another facility, or who temporarily stopped
Guidelines therapy and have started again in the time period should not be counted.
ART taken only for the purpose of prevention of mother-to-child transmission and post-
exposure prophylaxis are not included in this indicator. However, HIV-positive
pregnant women who are eligible for and initiate antiretroviral drug therapy for their
own treatment are included in this indicator.
This indicator is used to monitor trends in initiation but does not distinguish between
Interpretation: different forms of ART or to measure the cost, quality or effectiveness of treatment
provided.
10
Indicator #: Percentage of adults and children with advanced HIV infection currently receiving
HIV03-03 ARVs.
Programme Goal: The goal for KNASP III is to ensure that all HIV positive patients who meet the
treatment criteria receive ARV treatment.

Codes: 3.0.2 UNG-4 AOP-30 UA-G2 T1.2.D
CURRENT on ART: Refers to the number of patients currently on ART at a given

Definition of facility and does include patients who transfer in. Patients who transfer out, or are
Important Terms: categorized as DROP, DEAD, LOST or STOP, are subtracted.
Number of adults and children with advanced HIV infection who are currently
Numerator:
receiving antiretroviral therapy at the end of the reporting period.
Estimated number of adults and children with advanced HIV infection (in need of
Denominator:
ARVs).
Disaggregation: By sex: Male and Female, By age: <1, <15, 15+
Numerator:
Current on ART – (<1) HV03-16
Current on – Male (<15) HV03-17
Current on – Female (<15) HV03-18
Reportable Data
Current on – Male (15+) HV03-19
Elements:
Current on – Female (15+) HV03-20
Total Current on ART (Sum HV03-16..HV03-20) HV03-21
Denominator:
o Population-based estimate
This indicator assists in assessing progress towards set goals. These goals can be
Purpose: national or regional, yearly or multi-yearly depending on the application (strategic or
operational).
Data Collection Data should be collected continuously at the facility level and summarized monthly for
Frequency reporting.
Numerator: Facility ART registers/databases, program monitoring tools, or drug
Data Source
supply management systems.
Data for this indicator is generated by counting the number of adults and children who
are currently receiving ART in accordance with the nationally approved treatment
protocol at the end of the reporting period. The numerator should equal the number of
adults and children with advanced HIV infection who ever started ART minus those
Data Management patients who are not currently on treatment prior to the end of the reporting period.
Guidelines Patients excluded from the numerator are patients who died, stopped treatment,
transferred out or are lost to follow-up (patient not seen for 3 months from last visit).
Patients on ART who initiated or transferred in during the reporting period should be
counted. HIV-positive pregnant women who are eligible for and on antiretroviral drugs
for their own treatment are included in this indicator.
This indicator is used to monitor trends in coverage but does not attempt to distinguish
between different forms of ART or to measure the cost, quality or effectiveness of
treatment provided. The degree of utilization of ART will depend on factors such as
Interpretation:
cost relative to local incomes, service delivery infrastructure and quality, availability
and uptake of voluntary counseling and testing services, and perceptions of effectiveness
and possible side effects of treatment.
11
Indicator #:
HIV03-04 Number of adults and children with advanced HIV infection ever enrolled on ART
Programme Goal The goal for KNASP III is to ensure that all HIV positive patients who meet the
treatment criteria receive ARV treatment.

Codes: T1.4.D
Cummulative Ever Started on ART: Refers to the number of patients ever started on
Definition of ART as NEW at that specific facility, and does not include patients who transfer in.
Important Terms: Patients who transfer out, or are categorized as DROP, DEAD, LOST or STOP, are
not subtracted.
Number of adults and children with advanced HIV infection who have ever enrolled in
Numerator: ART at the facility, in accordance with the nationally approved treatment protocol at
the end of the reporting period
Denominator N/A
Disaggregation By sex: Male and Female, By age: <15, 15+
Numerator:
Ever Start ART – Male (<15) HV03-22
Ever Start ART – Female (<15) HV03-22
Ever Start ART – Male (15+) HV03-23
Reportable Data
Ever Start ART – Female (15+) HV03-24
Elements
Total Ever on ART (Sum HV03-21…HV03-24) HV03-25
Ever Start ART – Pregnant HV03-26
Denominator: None
To assess progress towards providing ART to all people with advanced HIV infection;
Coverage; Track progress towards legislative 5-year goals. Together with other ART
Purpose:
indicators provides some understanding of ART patient attrition. As well as describes
overall scale up of ART services
Data Collection Data should be collected continuously at the facility level and summarized monthly for
Frequency reporting.
Facility ART registers/databases, program monitoring tools, or drug supply
Data Source
management systems.
The numerator can be generated by counting the number of adults and children who
have ever enrolled in ART by the end of the reporting period. The numerator should
Data Management equal the number of adults and children with advanced HIV infection who newly
Guidelines started ART since the last reporting period added to those that had ever enrolled in
therapy in the last reporting period.
This indicator is used to monitor trends in coverage but does not attempt to distinguish
between different forms of ART or to measure the cost, quality or effectiveness of
treatment provided. The degree of utilization of ART will depend on factors such as
Interpretation:
cost relative to local incomes, service delivery infrastructure and quality, availability
and uptake of voluntary counseling and testing services, and perceptions of effectiveness
and possible side effects of treatment.
12
Indicator #: Percentage of adults and children with HIV known to be alive and on ART treatment
HIV03-05 12 months after initiation on antiretroviral therapy
Programme Goal: One of the goals of the ART programme is to increase survival among infected
individuals.

UA-
Codes: 3.0.1 UNG-24 G3a T1.3.D HIV-I3
Definition of ART Cohort analysis: Refers to a simplified cohort analysis which is a key component
Important Terms: of ART patient monitoring. It should not be confused with cohort studies which are a
demanding research activity. In patient monitoring of ART, a cohort is an ART start-up
group which consists of all patients starting ART in the same month. Cohort analysis
compares baseline characteristics of patients who started on ART with their status at 6
and 12 months, then yearly. It allows comparison of the proportion of patients
surviving on ART, remaining on the original first-line regimen (or substituting to an
alternative first-line regimen), and returning to the functional status of working (or
playing, for children).
Numerator: Number of adults and children who are still alive and on antiretroviral therapy at 12
months after initiating treatment.
Denominator: Total number of adults and children who initiated antiretroviral therapy, 12 months
ago.
Disaggregation: N/A
Elements: ART Net Cohort at 12 months HV03-27
On Original 1st Line at 12 months HV03-28
On alternative 1st Line at 12 months HV03-29
On 2nd Line (or higher) at 12 months HV03-30
On Therapy at 12 months (Sum HV03-28...HV03-30) HV03-31
Denominator:
o ART Net Cohort at 12 MONTHS
Purpose: The intention of ART provision is to prolong life of PLHIV. Therefore high retention is
one important measure of programme success and is a proxy for overall quality of
programme. This indicator builds up from the lower levels where additional
information is required covering longevity on a given line of drugs and the causes of
attrition.
Data Collection Data should be collected continuously at the facility level. Data should be aggregated at
Frequency: the end of the year in time for national reporting. However, selected facilities can
continuously monitor the trends over time (quarterly) as each month will have a cohort
that matures to 12 months.
Data Source: Program monitoring tools; ART registers/databases and cohort summary sheet.
Data Management The numerator requires that adult and child patients must be alive and on ART at 12
Guidelines: months after their initiation of treatment.
For a comprehensive understanding of survival, the following data must be collected:
• Number of adults and children in the ART start-up groups (less TOs plus TIs)
initiating ART at 12 months prior to the end of the reporting period (denominator)
• Number of adults and children still alive and on ART at 12 months after initiating
treatment (numerator)
The reporting period is defined as a continuous 12-month period that has ended within
a pre-defined number of months from the submission of the report.
Interpretation: At the national level, the number of transferred-in patients should match the number of
transferred-out patients. Therefore, the net current cohort (the patients whose outcomes
the facility is currently responsible for recording—the number of patients in the start-up
13
group plus any transfers in, minus any transfers out) at 12 months should equal the
number in the start-up cohort group 12 months prior.
14
Indicator #:
HIV03-07 Percentage of HIV patients screened for TB
Programme Goal The goal for KNASP III is to ensure that all HIV positive patients in care are screened
for TB on each visit.

Codes 3.3.3 UA-E3 C2.4.D TB-HIV1
Definition of Screening for TB: It is important to check the TB status of patients at each HIV care
Important Terms visit. Between 5% and 15% of HIV patients will develop TB disease each year. It is
therefore essential to determine TB status at each HIV care visit, to send sputums or
refer patients promptly for investigation when TB is suspected, and to make sure that
these results are used, that treatment starts promptly, and that TB and HIV care are well
coordinated. TB monitoring should be linked to HIV care/ART monitoring.
Numerator: Number of HIV positive patients screened for TB
Denominator: Number of HIV positive individuals in care [who made a clinical visit], during the
reporting period
Disaggregation: N/A
Elements Total screened for TB HV03-34
Total clinical visits HV03-35
Denominator:
o Total clinical visits
Purpose: TB disease is the leading cause of mortality among PLWH. Screening for TB among
PLWH at initial and subsequent visits is recommended to identify TB suspects and link
them to diagnosis and treatment.
Data Collection Data should be collected and collated continuously at the facility level and aggregated
Frequency: at the end of the reporting period. This indicator is reported quarterly.
Data Source: Revised versions (2010) of the Pre-ART/ART registers
Data Management The numerator can be generated by counting the number of HIV-positive adults and
Guidelines children in HIV care or treatment (pre-ART or ART) who were screened for TB disease
during the reporting period.
Note: For details, read up the procedures [2010 edition] for completing the revised ART
and Pre-ART Registers.
Interpretation: This indicator is intended to provide information on the proportion of HIV-positive
patients in HIV care and treatment who are screened for TB at last visit. It measures
HIV care/ART clinical team performance in checking TB status at every visit .This
could be measured by reviewing a sample of HIV care/ART cards during a visit by the
TB or ART district coordinator.
15
Indicator #: Percentage of TB/HIV co-infected clients who are started on ARVs.
Programme Goal: The TB/HIV indicators measure commitment and capacity of TB services or HIV
care/ART clinics to ensure that HIV-positive TB patients are able to access ART, and
that HIV/AIDS patients are regularly screened, diagnosed and treated for TB.

Codes: 3.3.1 UNG-6 UA-E1
Definition of TB/HIV co-morbidity: High co-morbidity between TB and HIV requires effective
Important Terms: coordination, referral and communication between TB and HIV/AIDS programme and
co-management of TB/HIV by clinical teams to enable effective care and treatment of
both diseases. Integrated monitoring and evaluation of the TB and HIV programmes
captures information on how well HIV prevention, diagnosis and care or referral for HIV
care take place within the TB programme and likewise, how well TB screening,
prevention and treatment is occurring in HIV care/ART programme.
Numerator: Number of TB/HIV co-infected adults and children on TB treatment who started on
ART during the reporting period.
Denominator: Total Number of TB/HIV co-infected patients still on TB treatment
Disaggregation: N/A
Elements Start ART-TB Patient HV03-15
TB Patient enrolled in Care [unallocated]
Denominator:
o TB Patient enrolled in Care
Purpose: ART significantly improves the quality of life, reduces morbidity, and enhances the
survival of people with advanced HIV infection or AIDS. HIV-positive TB patients are
one of the largest groups already in contact with the health service who are likely to
benefit from ART, and efforts should be made to identify and treat those who are
eligible. This indicator measures the degree to which ART has become a component of
the package of care offered to HIV-positive TB patients. As an outcome indicator it
measures commitment and capacity of TB services.
Data Collection Collected continuously and reported quarterly.
Frequency:
Data Source: Both numerator and denominator are obtained from the TB programme registers
Data This can be measured in the ART register by adding up the number of patients with a TB
Management treatment start date within the reporting period. This can be compared with TB/HIV
Guidelines: indicator captured by the TB programme, the number and percentage of HIV-positive
TB patients who are started on ART or continue previously initiated ART during or at
the end of TB treatment.
Interpretation: ART significantly improves the quality of life, reduces morbidity, and enhances the
survival of people with advanced HIV infection or AIDS. HIV-positive TB patients are
one of the largest groups already in contact with the health service who are likely to
benefit from ART, and efforts should be made to identify and treat those who are
eligible. This indicator measures the degree to which ART has become a component of
the package of care offered to HIV-positive TB patients and provides a measure of the
accessibility of ART to HIV-positive TB patients, drug availability, the degree to which
health-care providers encourage ART as a part of routine care, and the success of TB and
ART health services in referring, managing and tracking registered TB patients eligible
for ART (i.e. the strength of the referral process).
16
Indicator #: Proportion of women receiving Care screened for Cervical Cancer
HIV03-06
Programme Goal: To determine coverage of screening services for cervical cancer in HIV-positive women

Codes:
Definition of Cervical cancer: is a disease in which the cells of the cervix become abnormal and start
Important Terms: to grow uncontrollably, forming tumors.
Cervical cancer screening in HIV positive women: HIV positive women are more prone
to develop cervical cancer. It is recommended that because of this high risk, counselling
and regular cervical cancer screening using pap smear is performed for all HIV positive
women.
Numerator: Total number of HIV infected women in care screened for Cervical Cancer within HIV
care settings according to National guidelines
Denominator: Number of women in care who made a clinical visit (excl PMTCT) during the period
Disaggregation: None
Elements: Screened for cervical cancer (females 15+) HV03-32
HIV clinical visit – females (15+) HV03-33
Denominator:
o HIV clinical visit – Females (15+)
Purpose: Cervical cancer is the biggest cause of cancer deaths among women in sub-Saharan
Africa, due in large part to lack of screening. However, HIV infection and
immunodeficiency exacerbate the progression of pre-cancerous lesions, and the high
prevalence of cervical cancer and pre-cancerous changes in women with HIV has led to
efforts to incorporate cervical screening into HIV clinics and other health services. The
purpose of screening for cervical cancer is twofold.
o First, screening reduces the risk of cervical cancer by identifying women with
precancerous conditions that can be treated before the conditions progress to
cancer.
o Second, screening can identify women with cervical cancer before symptoms
appear.
Data Collection
Frequency: Data are collected/collated routinely and aggregated at the end of the reporting period .
Data Source: HIV care activity sheet
Data Management Only women screened outside the PMTCT settings should be counted and only one
Guidelines: count per women per reporting period.
Interpretation: This indicator is intended to provide information on the proportion of HIV-positive
women in HIV care and treatment who are screened for cervical cancer at last visit. It
measures HIV care/ART clinical team performance in screening for cervical cancer
among women at every visit.
17
<Nutrition for PLHIV>
Indicator #: Percentage of PLHIV (adults and children) receiving nutritional support
HIV03-09
Programme Goal: The goal of the nutrition care and support for PLHIV is to improve nutrition, health,
quality of life and duration of survival of people infected with HIV.

Codes: 3.4.1 C2.3.D
Definition of Nutrition: refers to the process how food is processed and utilized by the body for
Important Terms: growth , reproduction and maintenance of health.
Malnutrition: a condition in the body brought about by inadequate or excess intake of
required nutrients or malabsorption.
Numerator:
Number of CCC clients who received the minimum nutrition care package
Denominator: Number of clients who were nutritionally assessed and found to be clinically
malnourished during the reporting period.
Elements: Received package of nutrition care (<15) HV03‐38
Received package of nutrition care (15+) HV03‐38
Clinically malnourished (<15) HV03‐39
Clinically malnourished (15+) HV03‐39
Denominator:
o Clinically malnourished
Purpose: This indicator measures the coverage achieved for food support of clinically
malnourished clients. It can be used to plan interventions and allocation of resources for
food and nutrition as needed, and also to assess the impact of interventions.
Data Collection
Frequency: Data should be collected continuously at the facility level and reported monthly.
Data Source: Numerator can be obtained from the nutrition register while the denominator can be
obtained from the HIV care activity sheet.
Data Management The numerator can be generated by counting the number of clinically malnourished
Guidelines: clients who received therapeutic and/or supplementary food.
For details on procedures, refer to the “Kenyan Guidelines on Nutrition and

HIV/AIDS”
Interpretation: To address malnutrition and strengthen care and support, therapeutic, supplementary
and supplemental food provision has been introduced in the HIV program. Results
from this indicator provide information about the extent that food support is reaching
eligible clients and where gaps may exist.
The indicator provides information about coverage, but not about the duration of food
support provided to clients, drop-out rates, quality of the foods, or existence of
complementary interventions with the food.
Indicator #: Percentage of ART clients with improved nutrition status

HIV03-10
Programme Goal: The goal of the nutrition care and support for PLHIV is to improve nutrition, health,
18
quality of life and duration of survival of people infected with HIV.

Codes:
Definition of An improved nutrition status is desired for ART clients because when the immune
Important Terms: system is functioning properly, it helps slow the progression of HIV into AIDS and
increases survival. The achievement of the full function of the immune sytem requires
an array of essential micronutrients and adequate macronutrients achieved through
good nutrition.
Numerator: Number of adults and children ART clients found to be malnourished at initiation of
nutrition support that are considered to have recovered from malnutrition upon
completion of nutritional food support at 6mths.
Denominator: Total number of ART clients put on nutrition support who have matured to 6 months
at the reporting period.
Disaggregation: Disaggregation in age group (0-59mths; 5-17 yrs; 18+ yrs)

Elements Improved nutrition status (0-59 mths) HV03-40
Improved nutrition status (5-17 yrs) HV03-41
Improved nutrition status (18+ yrs) HV03-42
Total improved nutrition status (Sum HV03-40…HV03-42) HV03-43
Initiated food support 6 months ago (0-59 mths) HV03-44
Initiated food support 6 months ago (5-17 years) HV03-45
Initiated food support 6 months ago (18+) HV03-46
Total initiated food (Sum HV03-44…HV03-46) HV03-47
Denominator:
o Initiated food support 6 months ago (0-59 mths)
o Initiated food support 6 months ago (5-17 years)
o Initiated food support 6 months ago (18+)
o Total initiated food support 6 months ago (Sum above)
Purpose: Antiretroviral drugs can have both implicit and explicit consequences for the person
living with HIV/AIDS. Good nutrition is critical to the treatment, management and
success of any medical intervention against diseases-including HIV/AIDS. While good
nutrition cannot prevent HIV infection or cure AIDS, it can help to maintain and
improve the nutritional status of persons with the virus and very possibly, delay the
disease progression from HIV to AIDS—related diseases by boosting defenses.
Data Collection
Frequency: Data should be collected continuously at the facility level and reported monthly.
Data Source: Numerator can be obtained from the nutrition register while the denominator can be
obtained from the HIV care activity sheet.
Data Management The numerator can be generated by counting the number of malnourished ART clients
Guidelines: whose nutrition status improved from nutrition register.
Interpretation: Results from this indicator provide information about the extent that food support is
reaching eligible clients and improving their nutrition status.
19
<PMTCT and Infant Nutrition>
Indicator #: Number of pregnant women with known HIV status
HIV02-01
Programme Goal To increase the number of pregnant women who know their HIV status

Codes: P1.1.D
Definition of Pregnant women with unknown status: women who were not tested during ANC or at
Important Terms L&D for this pregnancy or did not have documented proof of having been tested during
ANC at L&D or PNC (<72 hrs) for this pregnancy.
Pregnant women with known HIV-infection: women who were tested and confirmed
HIV-positive at any point prior to the current pregnancy, who are attending ANC for a
new pregnancy.
Numerator: Number of pregnant women with known HIV status
Denominator: Optional: All pregnant women (ANC, L&D, PNC<72hrs)
Disaggregation: Disaggregate by Known positives at entry; Tested and picked results at (ANC, L&D,
PNC<72hrs)
Elements: ANC – Tested HV02‐01
L&D – Tested HV02‐02
PNC – Tested (<=72hrs) HV02‐03
ANC – known positive status at entry HV02‐04
Total Tested (Sum HV0201…HV0203) HV0205
Total with Known Status (Sum HV0201…HV0204) HV0206
Positive – ANC HV02‐07
Positive – L&D HV02‐08
Positive – PNC<72hrs HV02‐09
Total Positive (PMTCT) (HV0204 +Sum(HV0207…HV0209) HV0210
Denominator:
o Total (1st ANC visits, total deliveries, 1st PNC visits)
Purpose: Knowing ones HIV status in pregnancy is main entry point to prevention services
against mother-to-child transmission of HIV and other HIV care and treatment services.
It should be monitored over time to see the increase in the proportion of women
knowing their HIV status during pregnancy.
Data Collection Data should be collected continuously at the facility level and aggregated monthly for
Frequency: routine reporting.
Data Source: Both numerator(s) and denominators are collected using integrated HIV/AIDS-
maternal health data collection tools: antenatal, labour and delivery (L&D) and the
postnatal registers.
Data Management The numerator is the sum of the following categories of women at ANC, L&D and
Guidelines: PNC:
o Number of pregnant women who received an HIV test and result during ANC
o Number of pregnant women attending L&D with unknown HIV status who
were tested in the L&D and received results
o Women with unknown HIV status attending postpartum services within 72
hours of delivery who were tested and received results
o Pregnant women with known HIV infection attending ANC for a new
pregnancy.
20
Interpretation: This indicator monitors trends in HIV testing among pregnant women and uptake of
testing at PMTCT sites. The points at which drop-outs occur during the testing and
counseling process and the reasons why they occur are not captured by this indicator.
This indicator does not measure the quality of the testing or counseling. It also does not
capture the number of women who received pre- or post- test counseling.
There is a risk of double counting with this indicator, as a pregnant woman could be
tested multiple times during ANC, L&D, or postpartum. This is particularly true where
women get re-tested in different facilities, or where they come to the L&D without
documentation of their test. However, double counting should be minimized by
ensuring data collection and reporting system are using patient held and facility held
ANC records to document that testing took place.
21
Indicator #: Number of HIV positive pregnant women who received antiretroviral medicines to
HIV02-02 reduce the risk of mother to child transmission
Programme Goal: Scale up and increase access to PMTCT services all pregnant women who need them
and implementation of an evidence-based package of prevention of mother to child
transmission (PMTCT) interventions built around the use of antiretroviral drugs.

Codes: 2.3.1 P1.2.D
Definition of Mother-to-child transmission (MTCT): is when an HIV-infected woman passes the

Important Terms virus to her baby. This can occur during pregnancy, labour and delivery, or
breastfeeding. Without treatment with ARV prophylaxis, around 15-30% of babies born
to HIV positive women will become infected with HIV during pregnancy and delivery.
A further 5-20% will become infected through breastfeeding.
PMTCT: refers to preventing the transmission of HIV from HIV positive mothers to
their infants during pregnancy, labour, delivery and breastfeeding. In addition, use of
antiretroviral drugs in integration of HIV care, treatment and support for pregnant
women found to be positive and their families.
Numerator: Number of HIV positive pregnant women who received antiretroviral medicines to
reduce the risk of mother to child transmission (Disaggregated by Single dose, dual,
triple therapy and HAART)
Denominator: N/A
Disaggregation: Disaggregate by Single dose, dual, triple therapy & HAART.
Elements: Prophylaxis – Single dose HV02‐12
Prophylaxis – 2 ARVs HV02‐13
Interrupted HAART (3 ARVs) HV02‐14
HAART HV02‐15
Denominator:
o None
Purpose: This indicator is meant to measure the provision and uptake of antiretroviral
prophylaxis for the prevention of mother-to-child-transmission (PMTCT). The risk of
MTCT can be significantly reduced with the use of antiretrovirals for the mother, with
or without prophylaxis to the infant.
Data Collection Data should be collected continuously at the facility level and aggregated monthly.
Frequency:
Data Source: Numerator(s) are collected using integrated HIV/AIDS-maternal health data collection
tools: antenatal, labour and delivery (L&D) and the postnatal registers.
Data Management The numerator can be generated by counting the number of HIV-positive pregnant
Guidelines: women who received antiretrovirals to reduce MTCT during the reporting period, by
regimen.
Two methods for calculating the numerator can be used:

o
Counting at point of ARV provision: In rural areas where institution deliveries are
very low, the most reliable source of data for the numerator are the patient registers
based on where ARVs are dispensed and where the data is being recorded. There is
a risk of double counting in settings where ARVs are provided at different points in
time and/or in different service units or health facilities (e.g. a woman received SD-
NVP at post-test counseling and then received AZT at 28 weeks).
o
Counting at the end-point of labour and delivery: In settings with high facility
delivery rates (>90%), the data can be aggregated entirely from the L&D register by
22
counting the number of HIV-positive pregnant women who had received a specific
ARV regimen by the time of delivery (e.g., a woman received SD-NVP and AZT
during her pregnancy; at the time of delivery she would be recorded in the L&D
register as having received AZT+SD-NVP during pregnancy and included in
category #2). This may be the most reliable and accurate method for calculating
this indicator for settings with high facility deliveries, as the corresponding ARV
regimen dispensed is counted at the end of a woman’s pregnancy.
Note: Unfortunately method #2 will under count this service in most Kenyan facilities
due to low institutional deliveries.
Interpretation: This indicator is used to monitor: 1) the coverage of antiretrovirals given to HIV-
positive pregnant women to reduce the risk of HIV transmission to the child; and 2)
increased access to more efficacious ARV regimens for PMTCT. One weakness of this
indicator is the exclusion of mother-infant pairs who only received infant prophylaxis.
Therefore, partial prophylaxis for the infant only is not measured. The indicator
measures ARVs dispensed and not ARVs consumed, thus it is not possible to determine
adherence to the ARV regimen.
The national percentage is required for this indicator in order to better interpret
performance and service delivery and uptake and progress toward national goals and
scale-up.
23
Indicator #: Percentage of infants born to HIV-positive women who received an HIV test within 12
HIV02-07 months of birth.
Programme Goal: Expand and increase access to HIV testing services and care for all HIV exposed infants
within 12 months of birth.

Codes: C4.1.D
Definition of HIV exposed infants: Exposed infants can be infected with HIV antepartum,
Important Terms intrapartum, or postpartum (through breast feeding). However, while the child with
HIV infection can often be identified during the first months of life, HIV infection often
cannot be excluded until after 1 year of age particularly in breast feeding babies.
Numerator: No of HIV exposed infants who received a HIV test by 12 months
Denominator: All HIV exposed children registered at the facility who have reached the age of 12
months

Elements: Tested by 3 months - PCR HV02-25
Tested (3 - 9 months) - PCR HV02-26
Tested (9-12 months) - Serology HV02-27
Tested (9 – 12 months) - PCR HV02-28
Denominator:
o HIV-exposed that have reached 12 months
Purpose: WHO recommends national programmes to establish the capacity to provide early
virological testing of infants for HIV at 6 weeks, or as soon as possible thereafter to
guide clinical decision-making at the earliest possible stage. This is important because
infants exposed to HIV antepartum, intrapartum or postpartum do not usually live to
see their first birthday.
Data Collection Data should be collected continuously at the facility level and aggregated monthly in
Frequency: time for routine reporting
Data Source: HIV-exposed infant registers
Data Management The numerator, Number of infants who received an HIV test within 12 months in the
Guidelines: last 12 months, should be disaggregated as follows:
o Infants who received virological testing in the first 2 months
o Infants that were tested either virologically between 2 and 12 months, or by
serology between 9 and 12 months.
Infants tested should only be counted once. The numerator should only include the
initial test and not any subsequent tests.
Interpretation: This indicator is used to monitor progress in reaching HIV-exposed infants with early
infant testing as a critical tool for providing appropriate follow-up care and treatment.
This indicator does not capture the number of children with a definitive diagnosis (i.e.
either confirmed or excluded of HIV infection), or measure whether appropriate follow-
up services were provided to the child based on interpretation of test results. However,
a low value of the indicator could, however, signal potential bottlenecks in the system,
including poor management of HIV testing supply, poor data collection, and
mismanagement of testing samples etc.
24
Indicator #: Percentage of HIV exposed Infants by feeding type
HIV02-08
Programme Goal: Expand and increase access to HIV testing services and care for all HIV exposed infants
within 12 months of birth.

Codes: AOP-12 P1.6.D
Definition of The infant feeding practices measured in this indicator are defined as follows:
Important Terms: o Exclusive breastfeeding: An infant receives only breast milk and no other
liquids or solids, not even water, with the exception of drops or syrups
consisting of vitamins, mineral supplements or medicines for up to 6 months.
Breast milk also includes milk from a wet nurse and a mother’s expressed milk.
o Replacement feeding (no breast milk at all): The process of feeding a child
who is not receiving any breast milk with a diet that provides all the nutrients
the child needs until the child is fully fed on family foods. During the first six
months this should be with a suitable breast-milk substitute. The suitable
breast-milk substitute would normally be commercial infant formula, as home-
modified animal milk is no longer recommended for feeding infants during the
entire first six months of life except as an emergency measure. Replacement
feeding excludes breastfeeding.
o Mixed feeding: Feeding both breast milk and other foods or liquids for infants
0 - <6 months. After six months, exclusive breastfeeding or giving only
formula is no longer recommended.
Numerator: Numerator: Number of HIV exposed infants by feeding option (EBF, ERF, MF) at 6
months and (BF and Not BF) at 12 months
Denominator: Denominator: All exposed infants at 6 months and 12 months

Disaggregation: Disaggregate by age-band at 6 months and feeding (EBF, ERF, MF) and 12 months
(BF and Not BF)
Elements EBF (6 months) HV02‐29
ERF (6 months) HV02‐30
MF (6 months) HV02‐31
Total Exposed 6 months (Sum HV0229…HV0231) HV0232
BF (12 months) HV02‐33
Not BF (12 months) HV02‐34
Total Exposed 12 months (Sum HV0234…HV0235) HV0235
Denominator:
o HIV-Exposed – Sum of contacts at 6 months
o HIV-Exposed – Sum of contacts at 12 months
Purpose: This indicator is meant to assess the acceptability of each the available options for
IYCF in HIV-exposed infants and how well protocols are adhered to.
Data Collection Data should be collected routinely but summaries are compiled at the end of the
Frequency: reporting period from the HEI register.
Data Source: Both numerator and denominator can be obtained from the HEI register
Data Management During each visit, the health provider should inquire about infant feeding practices
Guidelines: during the previous 24 hours, asking the following questions:
“What did you give your infant to eat or drink yesterday during the day and during the
night?” After each response, the health provider should ask: “Anything else?” The
response will be recorded as one of the following: exclusively breastfeeding (EBF),
replacement feeding (RF), or mixed feeding (MF).
25
Interpretation: The numerator for this indicator is collected at every visit and reported at 6 and 12
months. The denominator is number of HIV-exposed infants who are being followed-
up and recorded in the HIV exposed infant register.
It should be noted that the indicator says nothing about the quality of replacement
feeding given, nor the impact of the feeding practices on child survival.
26
Indicator #: Proportion of HIV positive women assessed for ART eligibility (by WHO staging or
HIV02-04 CD4) at 1st ANC.
Programme Goal: To increase access to ART for HIV-infected pregnant women who meet clinical
immunological criteria.

Codes: P1.4.D
Definition of Assessment for eligibility: refers to determination of whether an HIV positive individual
Important Terms: by way of clinical or laboratory values (if CD4 or TLC available) meets the criteria to
start ART. Pregnant women who are medically eligible to start ART should have been
clinically diagnosed using WHO clinical staging, immunologically diagnosed using
CD4 count or a combination of both according to programme guidelines.
Numerator: Number of HIV positive women assessed for ART eligibility through either clinical
staging or CD4 at 1st ANC visit.
Denominator: First ANC visit of a HIV positive woman
Disaggregation: Disaggregate by type of assessment-(WHO staging and CD4 count)
By eligibility status for additional information on national trends in the percentage of
pregnant women who are eligible for ART.
By ART assessment type – clinical staging or CD4 testing.
Elements: Pregnant – ART eligibility – WHO HV02‐17
Pregnant – ART eligibility – CD4 HV02‐18
Denominator:
Total Pregnant ART Eligibility (Sum HV0217…HV0218) HV0219
Purpose: Care and treatment should be integral to the provision of PMTCT services. Focus
should not only be on averting transmission to the baby but equally important is
ensuring that the health of the mother is also cared for in the same setting.
This indicator therefore measures the level to which HIV-infected pregnant women are
assessed for ART eligibility through CD4 or WHO staging. Assessment can be onsite or
through referral.
Data Collection Collected routinely but analysed annually from district upwards. Facilities should do
Frequency: the analysis every quarter.
Data Source: Facility maternal registers, HIV sentinel surveillance in antenatal clinic estimates.
Data Management ART eligibility assessment can take place in a variety of settings, including in the ANC,
Guidelines: the laboratory, or in the care and treatment unit, on-site or by referral. If a patient is
assessed through both the CD4 and clinically, CD4 takes prominence and should be
counted under CD4
Interpretation: This indicator enables PMTCT programs to monitor the extent to which HIV-infected
pregnant women are receiving an intervention that is critical for accessing ART for their
own health. It does not capture whether HIV-infected pregnant women who were
eligible for ART actually received it. This indicator does not capture women who may
have been identified HIV-positive at labour and delivery and subsequently assessed for
ART eligibility. The value of indicator could be underestimated in situations where
women are referred to another facility for ART eligibility assessment.
Indicator #:
HIV02-06 Percentage of HIV Exposed Infants initiated on CTX within two months of birth.
Programme Goal: Expand and increase access to care for all HIV exposed infants
Codes: C4.2.D
27
Definition of Co-trimoxazole: is a combination of two antibiotics – sulfamethoxazole and
Important Terms: trimethoprim. It is widely available in a number of forms and is known by several brand
names. The most common use of cotrimoxazole is for the first-line management of
acute respiratory infections (ARI) in children, but it is also used to treat diarrhoea and
PCP, as well as infections of the urinary tract and middle ear.
Numerator: No of HIV Exposed Infants initiated on CTX within two months of birth.
Denominator: Known HIV Exposed Infants who have reached the age of two months of birth during
the reporting period

Elements: CTX to baby within 2 months HV03‐23
HIV‐exposed (reached 2 months) HV03‐24
Denominator:
o HIV-exposed (reached 2 months) during the reporting period
Purpose: Cotrimoxizole prophylaxis is a simple and cost-effective intervention to prevent
Pneumocystis jirovecipneumonia (PCP) among HIV-exposed and -infected infants.
This can occur before it is possible to detect HIV, therefore all infants born to HIV
positive mothers should receive co-trimoxazole prophylaxis starting at 4–6 weeks after
birth and continuing until HIV infection has been excluded in the absence of
breastfeeding.
Data Collection Data on initiation on CTX should be collected continuously at the facility level but due
Frequency: to sensitivity of this indicator around the age, analysis should be done annually by
reviewing HEI register for children that will have already reached 2 months – but
within the review period.
Data Source: Both numerator and denominator can be obtained from HEI registers
Data Management Numerator: The numerator is the sum of infants having received CTX within 2 months
Guidelines: of birth during the reporting period.
Denominator: This denominator will include a sum of infant cohorts that will have
matured to 2 months during the reporting period.
Interpretation: This indicator is used to monitor progress in reaching HIV-exposed infants with early
care and as a critical tool for providing appropriate follow-up care and treatment which
includes CTX prophylaxis treatment within 2 months of birth.
28
Indicator #: Percentage of infants born to HIV-infected women (HIV-exposed infants) receiving
antiretroviral prophylaxis to reduce the risk for peripartum mother-to-child transmission
Programme Goal: Infant antiretroviral prophylaxis to reduce peripartum transmission

Codes:
Important Terms: intrapartum, or postpartum (through breast feeding). However, while the child with
Numerator: Number of infants born to HIV-infected women during the past 12 months who were
started on antiretroviral prophylaxis to reduce peripartum mother-to-child transmission.
Denominator: Estimated number of live births to pregnant HIV-infected women in the past 12 months
Elements:
Denominator: None
Purpose: The risk for peripartum mother-to-child transmission can be significantly reduced by the
complementary approaches of providing antiretroviral drugs (as treatment or as
prophylaxis) for the mother with antiretroviral prophylaxis for the infant and use of safe
delivery practices and safer infant feeding.
Data Collection Data should be collected continuously at the facility level and aggregated monthly in
Frequency: time for routine reporting
Data Source: HIV exposed infants register
Data Management The numerator is calculated from national programme records aggregated from the HEI
Guidelines: registers at facility level. Antiretroviral drugs can be given to HIV-exposed infants
shortly after delivery, at facilities for labour and delivery for infants born at facilties, at
outpatient postnatal care or child clinics for infants born at home and brought to the
facility, or at HIV care and treatment or other sites. Three methods for calculating the
numerator can be considered:
• Counting at the point of antiretroviral drug provision: In settings with low
facility delivery rates, data for the numerator should be compiled from the sites
where antiretroviral drugs are dispensed and where the data are recorded.
There is a risk of double-counting when antiretroviral drugs are provided
during more than one visit or at different health facilities.
• Counting at the time of labour and delivery: In settings where a high
proportion of women give birth in health facilities, the numerator can be
estimated from only the labour and delivery register by counting the number of
HIV-exposed infants who received a specific antiretroviral drug regimen before
discharge from the labour and delivery ward. This may be the most reliable and
accurate method for calculating this indicator in settings with a high proportion
of facility deliveries, as the corresponding antiretroviral drug regimen dispensed
is counted at the time of provision to the infant.
• Counting at postnatal or child health sites: Reporting units can count and
aggregate the number of HIV-exposed infants who received antiretroviral
29
prophylaxis recorded at postnatal or child health clinics if attendance is high
and the exposure status of the child is likely to be known (e.g. from postnatal
registers, stand-alone registers or integrated HIV-exposed infant registers).
All public, private and nongovernmental organization-run health facilities that provide
antiretroviral drugs to HIV-exposed infants for the prevention of mother-to-child
transmission of HIV should be included. To estimate the denominator: multiply the
number of women who gave birth in the past 12 months (which can be obtained from
estimates by central statistics office) by the most recent national estimate of HIV
prevalence in pregnant women (which can be derived from HIV sentinel surveillance in
antenatal care clinics).
Interpretation: This indicator allows MOH to monitor their coverage of antiretroviral prophylaxis
dispensed or initiated among HIV-exposed infants to reduce the risk for peripartum
mother-to-child transmission of HIV. The indicator is a measure of the extent to which
antiretroviral drugs were dispensed for infants as prophylaxis for peripartum
transmission. As it does not capture whether the drugs were taken or for how long, it is
not possible to determine adherence to the regimen or whether the regimen was
completed.
30
Indicator #: Percentage of infants born to HIV-infected women (HIV-exposed infants) who are
breastfeeding provided with antiretrovirals (either mother or infant) to reduce the risk of
HIV transmission during the breastfeeding period
Programme Goal: Antiretrovirals to reduce transmission during breastfeeding

Codes:
Important Terms: intrapartum, or postpartum (through breast feeding). However, while the child with
Breastfeeding refers to either of the two practices:
o Exclusive breastfeeding: An infant receives only breast milk and no other
liquids or solids, not even water, with the exception of drops or syrups
consisting of vitamins, mineral supplements or medicines for up to 6 months.
o Mixed feeding: Feeding both breast milk and other foods or liquids for infants
0 - <6 months.
Numerator: Number of infants born to HIV-infected women who, during the past 12 months, are
breastfeeding and protected by an antiretroviral intervention to reduce mother-to-child
transmission through breastfeeding, namely either maternal or infant antiretroviral
drugs
Denominator: Estimated number of infants born to HIV-infected women (HIV-exposed infants) who
are breastfeeding during the past 12 months
Reportable Data
Elements:
Purpose: The overall risk of MTCT can be significantly reduced by providing antiretroviral drugs
(as lifelong therapy or as prophylaxis) to the mother and by complementary practices
related to safe delivery and appropriate infant feeding. In breastfeeding populations,
antiretrovirals interventions to mothers or infants can specifically reduce the risk of
transmission through breastfeeding.
Data Source: Both numerator and denominator can be obtained from the HEI register
Data Management The numerator is calculated from national programme records aggregated from HEI
Guidelines: registers at facility level. Antiretroviral drug interventions to reduce HIV transmission
through breastfeeding can be initiated shortly after delivery at facilities for labour and
delivery if infants are born at facilities, at outpatient postnatal care or child clinics for
infants born at home and brought to the facility, or at HIV care and treatment or other
sites.
The data for the numerator should be collected at the infant's 6 week visit (2-3 months)
and distinguished from ARV interventions given to prevent peripartum transmission.
Data on whether maternal or infant antiretrovirals to reduce post-natal transmission
were provided should be recorded for breastfeeding infants. HIV-infected pregnant
women who are eligible for antiretroviral therapy and are receiving a treatment regimen
31
and whose infants therefore benefit from the prophylactic effect of ART in reducing the
risk of transmission through breastfeeding are also included in this indicator.
Three methods for calculating the denominator can be considered:

Counting at the time of labour and delivery: In settings where a high proportion of
women give birth in health facilities, the denominator can be estimated from only the
labour and delivery register, by recording and counting the number of HIV exposed-
infants whose initial feeding practice was breastfeeding, as a proxy for the denominator
.
Counting at postnatal or child health sites: In settings where a high proportion of
women and children attend post-natal and child health sites, reporting entities can
count and aggregate the number of HIV-exposed infants who are breastfeeding recorded
at postnatal or child health clinics if the exposure status of the child is likely to be
known (e.g. from postnatal registers or stand-alone or integrated HIV-exposed infant
registers).
Combining data from labour and delivery + post-natal/child health sites : In some
settings, data for the numerator will need to be compiled from the labour and delivery
and postnatal and child health sites, to estimate the total number of HIV-exposed
infants who are breastfeeding. However, countries should establish data collection and
reporting systems to minimize double-counting.
All public, private and nongovernmental organization-run health facilities that provide
antiretroviral drugs to HIV-exposed infants for PMTCT should be included.
Interpretation: This indicator allows MOH to monitor the coverage of antiretroviral prophylaxis
dispensed or initiated among HIV-exposed infants to reduce the risk of post-natal HIV
transmission in breastfeeding populations. However, this indicator does not capture
whether the drugs were taken or for how long, so it is not possible to determine
adherence to the regimen or whether the regimen was completed.
32
Indicator #: Percentage of HIV-exposed children confirmed positive through a confirmatory test
HIV02-09
Programme Goal: To assess progress towards eliminating mother-to-child HIV transmission

Codes: UNG-25 P1.7.N
Definition of Confirmatory HIV test: HIV DNA PCR (polymerase chain reaction) should be
Important Terms: performed at age six to eight weeks followed by serial DNA PCRs. Two consecutive
positive DNA PCRs are considered diagnostic of HIV infection. If this is not available,
then all children should have HIV ELISA done at age eighteen months. Prior to
diagnosis, all children are to be monitored clinically for any signs or symptoms of HIV
infection.
The early diagnosis of HIV infection in infants is challenging in a resource-constrained
environment, both from a diagnostic and therapeutic perspective. Tests for antibodies to
HIV do not establish the presence of HIV infection in infants due to the transfer of
maternal antibodies; therefore, a virologic test is required. PCR-based techniques that
directly detect the existence of HIV in the plasma allow diagnosis by age one month.
Numerator: No of HIV exposed infants confirmed positive.

Denominator: Number of confirmatory tests done.
Disaggregation: N/A

Elements: Confirmed Positive – (by 3 months) – PCR HV02‐36
Confirmed Positive – (3 – 9 months) – PCR HV02‐37
Confirmed Positive – (9 – 12months) – PCR HV02‐38
Total Confirmed Positive (Sum HV0236…HV0229) HV0239
Denominator:
o Tested – (by 3 months)-PCR
o Tested – (by 3-9 months)-PCR
o Tested -(9-12 months)-PCR
Purpose: In the absence of preventative interventions, infants born to, and breastfed by, HIV-
infected women have roughly a one-in-three chance of acquiring infection themselves.
This can happen during pregnancy, during labor and delivery, or after delivery through
breastfeeding. The risk of MTCT can be reduced through the complementary
approaches of antiretroviral prophylaxis for the mother, with or without prophylaxis to
the infant, implementation of safe delivery practices, and use of safe alternatives to
breastfeeding. Antiretroviral prophylaxis followed by exclusive breastfeeding may also
reduce the risk of vertical transmission when breastfeeding is limited to the first six
months. This indicator allows assessment of progress toward eliminating mother-to-
child HIV transmission.
Data Source: HIV-exposed infant registers
Data Management The numerator, number of HIV exposed infants confirmed positive, should be
Guidelines: disaggregated as follows:
o Infants who received virological testing in the first 2 months
o Infants that were tested either virologically between 2 and 12 months, or by
serology between 9 and 12 months.
33
The numerator should only include the confirmatory HIV test.
Interpretation: This indicator allows one to assess the impact of PMTCT programs by estimating the
percentage of infants who are HIV-infected out of those born to HIV-infected pregnant
women and tested. This indicator offers PMTCT program teams the tools to monitor
the impact of PMTCT using actual data on the HIV status and survival of infants born
to HIV-infected women, gathered during follow-up health care visits with these infants
and recorded in the HIV Exposed Infants Register at health facilities.
34
Indicator #: Proportion of HIV infected women who received family planning services at 1st post-
HIV02-05 natal visits
Programme Goal: Prevention of unintended pregnancies among HIV-infected women—one of four
essential elements for comprehensive strategy to prevent HIV in infants.

Codes:
Definition of Family Planning: A program to regulate the number and spacing of children in a family
Important Terms: through the practice of contraception or other methods of birth control.
Numerator: HIV positive mothers at 1st post natal clinic who received FP
Denominator: All HIV positive women attending 1st post natal clinic
Disaggregation: Disaggregate by timing of postnatal visit and type of FP service offered

Elements: PMTCT–Receive FP Method –PNC HV02‐21
PMTCT‐ 1st PNC attendants HV02‐22
Denominator:
o PMTCT- 1st PNC attendants
Purpose: It is recommended that HIV infected women their partners or simply all HIV infected
women of child bearing age are provided with family planning counseling,
contraceptive methods or safer pregnancy counseling as part of routine care to reduce
unintended pregnancy and prevent maternal-to-child transmission. This indicator
measures access to FP services by HIV positive women during postnatal.
Data Collection Data should be collected routinely but aggregated monthly for reporting and local level
Frequency: analysis.
Data Source: Postnatal register
Data Management Although data are primarily obtained through a routine systems (self report by health
Guidelines: workers) other methods can also be used:
o Observation of service provision.
o Record reviews
Interpretation: The indicator suggests the extent to which women are referred to postpartum
counselling on FP but does not attempt to ascertain either the different contraception
options that are selected or the regularity with which they are used. Consequently, it
cannot reveal anything about the effectiveness of the advice given.
35
Indicator #: Percentage of pregnant women whose male partners were tested for HIV in the
HIV02-03 PMTCT setting.
Programme Goal: Increase participation of male partners in antenatal HIV counselling and testing

Codes:
Definition of Male partners testing for HIV in the PMTCT setting: refers to male partners of pregnant
Important Terms: women in attendance at antenantal clinic and being provided with HIV counselling and
testing services together with their partner.
Numerator: Number of male partners of pregnant women who tested for HIV within PMTCT
setting during reporting period.
Denominator: Number of pregnant women visiting the facility within reporting period

Elements: Male partners tested – ANC HV02‐11
Denominator:
o Number of pregnant women knowing their status at (ANC, L&D and PNC)
Purpose: It is recommended male partners be involved in PMTCT as part of process to reduce
stigma and discrimination as well as allow for provision of the necessary physical and
psychological and support and making joint decisions with partner about care for infant
beyond PMTCT.
Data Collection Data are collected routinely but analysis should be done quarterly at facility and
Frequency: annually at provincial and national levels
Data Source: Antenatal Register
Data Management In practice, women do not usually come with their partners during the first ANC visit
Guidelines: such that even when partner testing takes place in ANC, it is usually on subsequent
visits. As such there is a mismatch if data are analysed over short time interval such as
months due the lag in time between numerator and denominator. It is therefore advised
that analysis is done for broader periods
Interpretation: Involving men not only in the general prevention of HIV but in PMTCT specifically
could significantly increase the success of PMTCT. Increase in male involvement is
proxy for the support that pregnant will get both during and after delivery including
care for the newly born.
36
<Prevention: HTC>
Indicator #: Number of individuals who received Testing Counselling services for HIV and received
HIV01-01 their test results.
Programme Goal: The goal of Testing and counselling for HIV is to help individuals learn their HIV status
and increase uptake and improve access to HIV health services.

P11.1.D
Codes: 2.2.4 UA-A2 HIV-P8B
Definition of Testing and counselling services: refers to provision of information and prevention
Important Terms: counseling. All clients must receive information about the rapid test and give informed
consent for testing.
Receiving results: refers to provision of HIV test results to a clients following an HIV
testing and counselling session.
Numerator: Total number of individuals who received HTC services including their test results
Denominator: Total number tested
Disaggregation: Disaggregate by: Client type (1st test, retest); Client tested as (individual, couple+);
Setting (static, outreach); Test results (positive, negative); Sex (male, female); Age
(<10, 10-14, 15-24, 25-49, 50+); Pregnant; Tested (CSW,IDU,MSM, Other MARPS);
MARPS Tested positive.
Elements: Tested – First HV01‐01
Tested – Repeat HV01‐02
Total Tested (HV01-01+HV01-02) HV01‐03
Tested – Individual HV01‐04
Tested – Couples HV01‐05
Tested – Static HV01‐06
Tested – Outreach HV01‐07
Test results – Positive HV01‐08
Test results – Negative HV01‐09
Received results – Male (<10) HV01‐10
Received results – Female (<10) HV01‐11
Received results – Male (10-14) HV01‐12
Received results – Female (10-14) HV01‐13
Received results – Male (50+) HV01‐18
Received results – Female (50+) HV01‐19
Total received results (Sum HV01-11...HV21) HV01‐20
Tested – CSW HV08‐11
Tested – IDU HV08‐12
Tested – MSM HV08‐13
Tested – other MARPs HV08‐14
Total collected results (Sum TB01-...TB10-) HV08‐15
MARPS tested positive HV08‐16
o Pregnant;
Purpose: This indicator is meant to measure both the volume of people accessing the service
[useful for projecting programmatic needs such as test kits and other staffing resources]
and individuals’ level of knowledge of their HIV status. Testing is only useful if an
individual is made aware of the outcome of the testing so that informed decisions about
37
the future are made.
Data Collection Data should be collected, reviewed, and cleaned continuously at the facility level (or
Frequency: community level) and aggregated monthly for routine reporting.
Data Source: HTC Lab Register
Data Management To adequately collect data for this indicator, a minimum provision of the following
Guidelines: services is required: counselling, testing, return and receipt of test results.
*Couples counselling describe those sessions where two or more people in a
relationship come together for HIV T&C services. If a couple comes for services
together, they should be counselled together and receive their test results together,
where possible. When this happens data should be collected for each individual and it
should be indicated on the form that this was a couple session as opposed to an
individual session.
Interpretation: This indicator is intended to monitor trends in the uptake of testing and counseling over
time. However, in some cases, data for this indicator might include repeat testers.
Repeat testing is common practice among most HIV T&C programs and it is important
to recognize this and interpret the aggregated data with caution.
Over time, the number of people who are expected to be tested and counseled will vary
depending on numerous factors such as, the numbers of people with previously
confirmed positive status, or the number of people who may be at perceived risk of HIV
infection, and hence this indicator should be interpreted accordingly.
Finally, this indicator does not provide information on whether those who were tested
were adequately referred to and are receiving follow up services to benefit from
knowing their HIV status.
38
TB Indicators not yet submitted by TB team
Indicator #: Percentage of TB patients tested for HIV and collected test results.
Programme Goal: The goal of collaborative TB/HIV activities is to reduce the burden of HIV in TB
patients.

Codes 3.3.2 C3.1.D
Definition of HIV testing for TB patients: This refers to the routine provision of HIV testing and
Important Terms counseling services for all TB patients aimed at reducing the HIV burden among TB
patients.
Numerator: Number of newly registered TB patients who were tested for HIV and collected results
during a given period
Denominator: Total number of TB patients registered during the same time period.
Disaggregation: Disaggregate by sex and age group: <15 and 15+ years

Elements o TB patient collected test results – Males (<15)
o TB patient collected test results – Females (<15)
o TB patient collected test results – Males (15+)
o TB patient collected test results – Females (15+)
Denominator:
o TB patient registered – Males (<15)
o TB patient registered – Females (<15)
o TB patient registered – Males (15+)
o TB patient registered – Females (15+)
Purpose: Ensuring that TB patients receive HIV counselling and testing services should be a high
priority due to the following reasons:
♦ Reduce morbidity and mortality among people living with HIV arising from TB.
♦ Early detection of HIV to enable access to appropriate care
This indicator therefore measures the coverage of HIV testing among tuberculosis (TB)
patients.
Data Collection Collected continuously and reported with the quarterly cohort outcome data.
Frequency:
Data Source: Quarterly Report on TB Case Registration
Both numerator and denominator are obtained from TB registers and should be
summarised on the quarterly TB treatment outcome reports.
Data Management Data for this indicator can be collected using national programme records aggregated
Guidelines: from facility registers, either the TB register or a separate HIV testing and counselling
register.
Interpretation: Tracking this number provides information on whether provider-initiated HIV testing
and counselling is being targeted and provided appropriately to patients with TB, so
that HIV-positive TB patients can access appropriate HIV services.
This indicator is intended to provide information on the proportion of TB patients with
documented HIV status. We assume that if a patient has documented HIV status, the
patient knows his or her HIV status. Known HIV status among TB patients reflects
overall efforts to increase HIV testing.
39
<Male circumcision >
Indicator #: Number of males circumcised as part of the minimum package of MC for HIV
HIV04-01 prevention services
Programme Goal Reduce men’s risk of infection with HIV through vaginal intercourse, there by
contributing to preventing the spread of HIV/AIDS in the general population.

Codes: 2.4.1 P5.1.D
Definition of Male circumcision: refers to the surgical removal of the foreskin, the tissue covering the
Important Terms: head of the penis. It is widely practiced for religious and traditional reasons, often
within the first two weeks after birth or at the beginning of adolescence as a rite of
passage into adulthood. As a medical procedure, it is also performed to treat problems
involving the foreskin. As a prevention for HIV prevention services.
Numerator: Number of males circumcised as part of the minimum package of MC for HIV
prevention services (counselling & testing, STI screening & treatment, ABC, local
anaesthesia and follow-up) per national standards and in accordance with a clinical
manual within the reporting period.
Denominator: None
Disaggregation:
Disaggregate by: age group (< 1, 1- 4, 15-19 , 20-25 and 25+, HIV status)
Elements: Circumcised – (< 1) HV04-01
Circumcised – (1 to 14) HV04-02
Circumcised – (15-19) HV04-03
Circumcised – (20-25) HV04-04
Circumcised – (above 25) HV04-05
Total Circumcised (Sum HV04-01...HV04-05) HV04-06
Circumcised – (Positive) HV04-07
Circumcised – (Negative) HV04-08
Circumcised – (Unknown) HV04-09
Denominator:
o None
Purpose: For optimal effect on the population, uptake of male circumcision should be as high
and as rapid as safely possible. The total number of males circumcised indicates either
change in the supply of or demand for MC services. Additionally, disaggregated
information may be useful to evaluate whether prioritized services have been successful,
set targets have been achieved, and modeling inputs should be adjusted.
Data Collection
Frequency: Collected routinely and reported monthly
Data Source: Theatre Register
Data Management The sum of clients documented as having received MC within the reporting period from
Guidelines: the theatre register.
Interpretation: This is the actual number of males circumcised in accordance with the
WHO/UNAIDS/Jhpiego Manual for Male Circumcision Under Local Anesthesia so
that the overall uptake and delivery of MC minimum services package in the country
can be monitored, outcomes evaluated, and impact of MC on HIV incidence at a
population level can be modeled. Comparing current and previous values may indicate
newly implemented service delivery or changes in supply or demand volume.
40
41
Indicator #: Number of MC clients who experienced one or more moderate or severe adverse
HIV04-02 events within the reporting period
Programme Goal: Reduce men’s risk of infection with HIV through vaginal intercourse, there by
contributing to preventing the spread of HIV/AIDS in the general population.

Codes: P5.2.D
Definition of Moderate/Severe Adverse Events: Refers to the seriousness of the reported adverse
Important Terms: event (AE). These events may include anesthesia reaction, bleeding, infection, pain,
wound disruption, sexual dysfunction, injury to glans which are classified as mild,
moderate or severe in accordance with the seriousness. The severity of the AE may
require medical treatment or hospitalization or referral to another facility.
Numerator: Number of moderate or severe adverse events as per defined standards in the clinical
manual within the reporting period.
Denominator: N/A
Disaggregation: By severity (moderate / severe; By timing (during / post MC)

Elements: During –AE(s)– moderate HV04-10
During– AE(s) – severe HV04-11
Post –AE(s)– moderate HV04-12
Post– AE(s) – severe HV04-13
Denominator:
o None
Purpose: Like all surgeries, male circumcision is not without risk, and the performance and
reporting of safe MC services depends in part upon skill and quality of surgery,
effectiveness of post-operative instructions, willingness or ability of the patient to follow
post-operative instructions, suitability of the surgical candidate, level of CD4 count if
HIV-positive, and the judgment of the healthcare personnel assessing AEs. Intra- and
post-operative complications must be monitored to ensure maximization of the
provision of safe, quality MC services, and in turn engender trust in communities and
foster high demand for MC services.
Data Collection Data are collected during surgery and thereafter
Frequency:
Data Source: Adverse Events Forms
Data Management Sum of clients experiencing moderate and severe adverse events documented in
Guidelines: Adverse Event Form.
o It is the date of surgery, not the date of AE(s) that must fall within the reporting
period.
o For reporting purposes, AEs include MC cases involving an occupational
exposure to blood/body fluids. Occupational exposure to blood/body fluids
(splash, sharps injuries) are based upon guidelines set forth in the WHO/ILO
Post-exposure Prophylaxis to Prevent HIV Infection
Interpretation: This indicator measures the number clients experiencing moderate or severe adverse
events to allow for monitoring of safe, quality service provision. Frequency and
frequency of severity, of AEs above ‘an acceptable level’ is an indication of the need for
investigation into causes and possible interventions. Further, disaggregation by timing
of adverse event may inform planning of post-operative care considerations, particularly
from mobile/remote services that may have limited availability following surgery.
Disaggregation by specific type of AE may help determine the need for additional
training to prevent or manage certain complications.
42
43
< Post-exposure Prophylaxis (PEP)>
Indicator #: Proportion of people (other than in PMTCT) reported to be exposed to HIV who was
HIV05-01 provided with post-exposure prophylaxis within 72 hours of exposure.
Programme Goal: The goal of Post exposure prophylaxis (PEP) is to provide a medical response to
prevent the transmission of pathogens after potential exposure.

Codes 2.5.2 P6.1.D
Definition of Post exposure prophylaxis for HIV: refers to a set of comprehensive services to prevent
Important Terms infection in the exposed person. These services include first aid care, counselling and
risk assessment, HIV testing following informed consent, and depending on risk
assessment, the provision of short term (28 days) antiretroviral drugs, with follow up
and support.
Numerator: Number of people provided with post-exposure prophylaxis (PEP)
Denominator: Total number exposed and reported
Disaggregation: By sex age and reason
Elements Exposed – Occupational – male HV05‐01
Exposed – Occupational – female HV05‐02
Exposed – Sexual assault – male HV05‐03
Exposed – Sexual assault – female HV05‐04
Exposed – Other reasons ‐ male HV05‐05
Exposed – Other reasons ‐ female HV05‐06
Total Exposed (Sum HV0501...HV0506) HV0507
PEP – Occupational – male HV05‐08
PEP – Occupational – female HV05‐09
PEP ‐ Sexual assault – male HV05‐10
PEP ‐ Sexual assault – female HV05‐11
PEP ‐ Other reasons – male HV05‐12
PEP ‐ Other reasons – female HV05‐13
Total PEP (Sum HV0508...HV0513) HV1614
Denominator:
o Exposed – Occupational – male
o Exposed – Occupational – female
o Exposed – Sexual assault – male
o Exposed – Sexual assault – female
o Exposed – Other reasons - male
o Exposed – Other reasons - female
o Total Exposed (Sum above)
Purpose: PEP reduces the probability of HIV infection after exposure to potentially HIV-positive
blood or body fluids. PEP should be provided within 72 hours after exposure for
maximum effectiveness. PEP may be provided for occupational, as well as non-
occupational exposure (such as after sexual assault). The data that will be collected
through this indicator provides information to answer questions around prevention,
program quality, human resources for health, gender, and overall health system
strengthening. This information can also assist in scaling up PEP services.
Data Collection Data will be collected as the event takes place
Frequency:
Data Source: PEP Register
Data Management The indicator can be generated by counting the number of individuals receiving PEP for
44
Guidelines: occupational and non-occupational purposes. Individuals should be counted only one
(1) time.
Interpretation: This indicator does not intend to capture the type and quality of PEP services provided.
PEP services may include first AID, counselling, testing, provision of ARVs, medical
care, trauma counselling, linkages with police, and other follow-up and support. Simple
monitoring of PEP availability through program records does not ensure that all PEP-
related services are adequately provided to those who need them.
45
< Blood Safety>
Indicator #: Percentage of donated blood units screened for TTIs in a quality assured manner
HIV06-01 (Includes HIV, Hepatitis B, Hepatitis C, Syphilis)
Programme Goal: To eliminate or substantially reduce HIV and other transfusion-transmissible infections
(TTIs) through a blood safety programme.

Codes: 2.6.1 UNG-3 AOP-32 P2.1.N HIV-P17
Definition of Quality Assured Manner: The overall goal of the National Blood Transfusion Services
Important Terms is to ensure that only blood products of demonstrated quality, safety and efficacy are
used. NBTS has put in quality assurance systems to control quality and safety of blood
products to assure quality and safety of blood and plasma and to prevent transmission
of blood-borne viral diseases via blood products.
Numerator: Number of blood units screened for TTIs in a quality assured manner
Denominator: Total number of blood units donated
Disaggregation:
Elements Donated blood units HV06-02
Blood units screened for TTIs HV06-03
Screened in quality-assured manner HV06-04
Denominator:
o Blood units donated
Purpose: Blood safety programs aim to ensure that all blood units are screened for transfusion-
transmissible infections, including HIV, and that only those units that are non-reactive
on screening tests are released for clinical use. Universal screening of donated blood for
HIV and other transfusion transmissible infections cannot be achieved without
mechanisms to ensure quality and continuity in screening. It is crucial that all donated
blood units be screened for HIV in a quality assured manner. The following
methodologies are two key components of quality assurance in screening.
1. The use of documented standard operating procedures for the screening of every
blood unit.
2. Participation of the laboratories in an External Quality Assessment Scheme for HIV
screening in which external assessment of the laboratory’s performance is conducted
using samples of known, but undisclosed, content to assess its quality system and assist
in improving standards of performance.
Data Collection Annual
Frequency:
Data Source: Routine program monitoring and assessment.
Data Management Explanation of numerator: For the purposes of data collection screening in a quality
Guidelines: assured manner is defined as screening performed in blood centers/blood screening
laboratories that (i) follow documented standard operating procedures and (ii)
participate in an external quality assurance (EQA) scheme
Explanation of denominator: In this context, donation refers to any blood collected for
the purposes of medical use.
The following information is required to measure this indicator.
1. The total number of blood units that were donated
2. For each blood screening laboratory/center that screens donated blood for HIV:
i. The number of units of blood donated in each blood laboratory/center;
ii. The number of donated units screened in the blood laboratory/center;
iii. If the blood screening laboratory followed documented standard operating
46
procedures for HIV screening;
iv. If the blood screening laboratory participated in an External Quality Assessment
Scheme for HIV screening. From this information, the indicator can be calculated.
Interpretation: If the blood screening laboratory follows documented and standardized procedures for
the screening of blood, this implies a certain level of uniformity, reliability and
consistency of performance by staff trained to use the standard operating procedures. If
a blood screening laboratory participates in an External Quality Assurance Scheme, this
implies that the quality of HIV screening performed is being assessed at regular
intervals. It is important to view the percentage of screened blood units in relation to
these two basic components of quality as both are required to ensure the quality of
procedures.
47
Indicator #: Number of units of whole blood collected by NBTS networks and screened for TTIs
HIV06-02 per 1,000 population per year

P2.2.D,
Codes: P2.2.N
Definition of Every unit of whole blood collected by facilities in the NBTS network must be screened
Important Terms: for HIV, HBV, HCV, and syphilis in order to be counted as “collected and screened by
the NBTS network.” The numerator, therefore, reflects the safety as well as the quantity
of blood collected each year. NBTS program managers must be vigilant throughout the
year to ensure that quality controls are maintained at all of the laboratories (public and
private) contributing screened units to this numerator. In order to be available for
transfusion, units must also not have been discarded for any other reason (e.g.,
contamination, leak).
Numerator: Number of units of whole blood collected by NBTS networks and screened for TTIs per
1,000 population per year
Denominator: N/A
Disaggregation:
Elements Units of whole blood screened for TTIs HV06-05
Denominator:
o Estimated target population
Purpose: Often, even when screening does occur, the safety of blood is compromised by
inaccurate test results due to the poor quality or incorrect storage of test kits.
Furthermore, inadequate staff training or a lack of standard operating procedures may
result in laboratory errors. This could lead to blood units being classified as safe even
when they are infectious, posing a serious risk of transmission of HIV through unsafe
blood. Thus, it is crucial that all donated blood units be screened for HIV in a quality
assured manner.
Data Collection Data on the number of whole blood units collected and screened by the NBTS network
Frequency: should be collected continuously at the facility level, and reported quarterly for the
purpose of programmatic management and review. The number of whole blood units
collected, screened and made available for transfusion per 1,000 populations should be
reported annually.
Data Source: NBTS will enter blood collection and screening information into electronic database,
including a count of the number of units discarded due to reactivity for any of the four
TTI, and a count of the number of units discarded for any other reason (e.g.,
contamination or damage/loss during the collection or screening process). With these
data, the database calculates the number of “safe and available” units after discards for
TTI reactivity and other causes are subtracted from the total number of units collected.
Specifically, the numerator will be drawn from the question, “Total number of whole
blood units collected and screened by the NBTS that were determined to be safe and
available for transfusion after TTI screening. (Units available for screening – Total
discards).”
Data Management The number of units of whole blood collected by the National Blood Transfusion
Guidelines: Service (NBTS) network: The NBTS network includes NBTS and non-NBTS blood
collection facilities, some of which screen 100% of the blood they collect using the
NBTS screening algorithm. Others send 100% of the blood they collect to be screened
by an NBTS laboratory. The NBTS data service will monitor collection, screening and
48
discard data on a routine basis and ensure these data from all network facilities are
aggregated on an annual basis. To obtain the number of units collected and screened
per 1,000 population per year, the aggregated annual total should be multiplied by
1,000 and divided by the national population.
Interpretation: This indicator is designed to measure the National Blood Transfusion Service’s progress
toward meeting or exceeding the WHO recommended targets to ensure an adequate
supply of blood. This indicator will also indirectly measure the Service’s ability to
provide blood that has been laboratory screened for four transfusion-transmissible
diseases (HIV, HBV, HCV, syphilis). Preventing new infections with any or all of these
pathogens will save lives and reduce the burden of disease on national health care
systems.
49
Indicator #: Percentage of blood units screened and found positive for HIV by NBTS network
HIV06-03

Codes P2.4.N
Definition of Blood units screened and found HIV positive: Refers to blood which has been collected
Important Terms: from voluntary blood donors, tested for HIV infection and found to be reactive.
Numerator: No of blood units screened and found positive for HIV by NBTS networks
Denominator: Total blood units screened for HIV by NBTS networks
Disaggregation: N/A
Elements Blood units reactive to HIV HV06-06
Blood units screened for HIV HV06-07
Denominator:
o Blood units screened
Purpose: A well-coordinated national blood transfusion service (NBTS) is a source of safe blood.
The safety of NBTS blood is the result of two primary activities: 1) The collection of
blood from low-risk voluntary, non-remunerated donors; and 2) Quality assured
laboratory screening of all units for four main transfusion-transmissible infections, or
TTI (HIV, HBV, HCV and syphilis).
Based on aggregated annual data on the number NBTS-collected blood units which are
screened for HIV in an NBTS network laboratory, and the number of these units which
are identified as reactive for HIV. This indicator will serve as the HIV sero-prevalence
estimate for the national blood donor pool.
The MoH has developed standards for HIV screening and establishing safe blood
transfusion status. Successful outcomes of the blood safety program can be measured by
monitoring how many blood units are screened according to MoH standards.
Data Collection All NBTS laboratories maintain daily screening logs, and most report HIV reactive
Frequency: units to the blood bank on a daily basis to ensure these units are removed from
quarantine and discarded promptly. The NBTS aggregates data on the number of units
screened for HIV and HIV reactive units quarterly for programmatic reporting. These
quarterly totals are aggregated at the mid-point and end of each year.
Data Source: For the numerator and denominator: NBTS will enter blood collection and screening
information into electronic database, including a count of the number of units discarded
due to reactivity for any of the four TTI, and a count of the number of units discarded
for any other reason (e.g., contamination or damage/loss during the collection or
screening process). With this information, the database, will be used to collect and
aggregate data on the number of blood units screened for HIV and the number of these
units which are identified as HIV reactive.
Data Management Numerator: NBTS laboratories will report HIV screening results to NBTS data
Guidelines: managers on a routine basis (often daily). NBTS data managers will enter information
on HIV reactive units into the database. The database will automatically aggregate this
data on a quarterly, semi-annual, and annual basis.
Interpretation: This indicator has three principal uses:
1) It will track the prevalence of HIV in the donor pool.
2) The numerator may be used to estimate the number of HIV infections averted by
adequate laboratory screening.
3) The denominator may serve to monitor the NBTS laboratory network’s capacity to
screen a larger volume of blood.
50
51
<Abstinence, Be faithful, and Consistence condom use (ABC)>
Indicator #: Number of the targeted population reached with individual and/or small group level
HIV07-01 preventive interventions that are primarily focused on abstinence and/or being faithful,
and are based on evidence and/or meet the minimum standards required
Programme Goal: Promotion of the ABC behavioural strategies to reduce HIV transmission.

Codes: P8.2.D
Definition of ABC strategy: refers to "population-specific interventions" that emphasise:

Important Terms: Abstinence for youth, including the delay of sexual debut and abstinence until marriage
Being tested for HIV and being faithful in marriage and monogamous relationships
Correct and consistent use of condoms for those who practice high-risk behaviours.
Those who practice high-risk behaviours include "prostitutes, sexually active discordant
couples [in which one partner is known to have HIV], substance abusers, and others".
Numerator: Number of target population reached with individual and/or small group level HIV
prevention interventions that are primarily focussed on abstinence and/or be faithful
and are based on evidence and/or meet the minimum required standards.
Denominator: Total number of intended target population in the catchment population
Disaggregation: Sex (male/female); Age(10-14, 15-19, 20-24, 25+)

Elements: Reached with ABC – male(10-14) HV07-01
Reached with ABC – female(10-14) HV07-02
Reached with ABC – male(15+) HV07-03
Reached with ABC – female(15+) HV07-04
Total Reached with ABC(Sum HV07-02…HV07-04) HV07-05
Denominator: N/A
Purpose: This information will be used to report to congress on AB only interventions.
Data Collection Data should be collected continuously at the organization level. Data should be
Frequency: periodically aggregated, i.e. quarterly, for the purposes of program management and
review as well as meeting semi-annual and annual reporting requirements.
Data Source: Data can be obtained from program monitoring tools.
Data Management Explanation of Numerator
Guidelines: The numerator can be generated by counting the number of de-duplicated individuals
from an activity defined target population who are reached primarily through AB
prevention intervention.
Primarily focused: The messages and content of the activities spend the majority of
their time discussing; increasing individual and group’s self-risk assessments; building
the skills; and other supportive behavioral, cognitive and social components to increase
the AB behaviors.
Abstinence and/or being faithful: AB interventions can include programs, services,
and messages which encourage sexual abstinence, delay of sexual debut and secondary
abstinence, mutual fidelity, mutual knowledge of HIV status, and social and gender
norms which promote mutual respect and open communication about sexuality. AB
interventions can also include programs, services, and messages which discourage
multiple and/or concurrent partnerships, cross-generational and transactional sex,
sexual violence, stigma, and other harmful gender norms and practices. AB
interventions targeting youth should support skills-based sexuality and AIDS education
as well as involve parents and guardians to improve communication with children and
parenting skills.
52
Explanation of Denominator:
Catchment area: Geographic region from which persons come to receive HIV
prevention services, or from which persons are being recruited into HIV prevention
services.
Interpretation: This indicator provides information on the total number of unduplicated individuals
that received individual-level and/or small-group level interventions. These
interventions are based on evidence and/or meet the required minimum standards. The
information collected will allow for assessment of any changes in risk behaviors as a
result of the implemented interventions. The information will also help in
understanding the efficacy and effectiveness of evidence-based interventions and help in
further expansion of similar interventions.
53
< Routine Indicators for MARPs Services>
Indicator #: Number of MARP reached with individual and/or small group level interventions that
HIV08-01 are based on evidence and/or meet the minimum standards required
Programme Goal: Increased access to HIV/AIDS and reproductive health services for MARPs and their
sexual partners

Codes: P8.3.D
Definition of ) MARPs = Most at risk populations; includes female and male sex workers, men who
Important Terms: have sex with men, injecting drug users, prisoners, truckers
2) Range of HIV/STI package of services proposed in National Guidelines for Sex
Worker HIV/STI Interventions includes Basic, Clinical, Non-Clinical and Enabling
Environment which comprise of the following components:
• Basic: Outreach and peer education; Risk assessment, risk reduction counseling
and skills building; demonstration and distribution of condoms and lubricants and
promotion of 100% condom use
• Clinical: HIV testing and counseling; STI screening and treatment; TB screening
and referral to treatment; HIV care and treatment; Reproductive health services
(FP, PAC, cervical cancer screening); emergency contraception; PEP; Substance
abuse, assessment and treatment
• Non-Clinical: Psychosocial support; Services to mitigate sexual violence; Family
and social services; Support to expand choices beyond sex work
• Enabling Environment: Community mobilization; Behaviour change
communication; service provider sensitization and training; Stigma and
discrimination reduction
The MARPs TWG intends to expand the guidelines to cover other MARPs sub-
populations (MSMs, IDUs, etc.)
Numerator: Number of MARPS reached with individual and/or small group level prevention
interventions that are based on/or meet the minimum required standards.
Denominator: Total number of intended target population in the catchment population
Disaggregation: Sex (male/female); MARP Type (CSW, IDU, MSM, others)
Reportable Data Numerator :
Elements: MARP–reached-CSW HV08-01
MARP–reached-IDU HV08-02
MARP–reached-MSM HV08-03
MARP–reached-Other HV08-04
Total MARPS–reached Sum HV08-01…HV08-04) HV08-05
Denominator: N/A
Purpose: Individual and small-group level prevention interventions have been shown to be
effective in reducing HIV transmission risk behaviors. Delivering these interventions
with fidelity to the appropriate populations is an important component of combination
HIV prevention strategies.
Data Collection Collect daily and report monthly
Frequency:
Data Source: MOH 711 and COBPAR based on data from daily tally sheets and facility registers
Data Management Frontline service provider summarizes the monthly service statistics and fills summary
Guidelines: form for service delivery point; the HRIO or site/program in-charge completes the
MOH 711 form and submits to the DHRIO who aggregates the district level statistics
and uploads summary to web-based database which is accessed at central level by HIS
and NASCOP MARP Manager for quarterly program reviews.
54
that received and completed individual-level and/or small-group level interventions.
These interventions are based on evidence and/or meet the required minimum
standards. The indicator will help to determine reach and coverage to help the program
understand the extent and reach for further expansion.
55
Indicator #: Number of MARPS reached with individual and/or small group level HIV/STI
HIV08-02 package of services as per national guidelines
Programme Goal: Increased access to HIV/STI and reproductive health services for MARPs and their
sexual partners
Reduced HIV/STI risk and burden among MARPs and their sexual partners

Partially
Codes: #9 P8.3.D P4b
Definition of 1) MARPs = Most at risk populations; includes female and male sex workers, men who
2) Range of HIV/STI package of services proposed in National Guidelines for Sex
Worker HIV/STI Interventions includes Basic, Clinical, Non-Clinical and Enabling
Environment which comprise of the following components:
The MARPs TWG intends to expand the guidelines to cover other MARPs sub-
populations (MSMs, IDUs, etc.)
Numerator: Number of MARPS that received one or more HIV/STI services at targeted sites during
the reporting period
Denominator: None
Disaggregation: By Sex-Male/Female, MARP type-MSM, SW,IDUs
Elements: STI Service - CSW HV08-06
STI Service - IDU HV08-07
STI Service - MSM HV08-08
STI Service - Other HV08-09
Total MARPS–HIV/STI(Sum HV08-06…HV08-09) HV08-10
Denominator: N/A
Purpose: Assess coverage and uptake of HIV/STI services for MARPS as per set targets
Identifying program gaps
For program planning and budgeting
Frequency:
Data Source: MOH 711 and COBPAR based on data from daily tally sheets and facility registers
Data Management Frontline service provider summaries the monthly service statistics and fills summary
MOH 711 or COBPAR form and submits to the DHRIO and CACC Coordinator who
aggregates the district/constituency level statistics and uploads summary to web-based
database which is accessed at central level by HIS, NASCOP and NACC
Interpretation: This number provides information on the total number of unduplicated individuals that
56
received and completed HIV/STI interventions provided at the individual and group
levels. It will provide insight to what extent MARPs have been reached in order to
guide future expansion
57
Indicator #:
HIV08-03 Number of HIV positive MARPS provided with HIV care referral
sexual partners

Codes:
2) Range of health care referrals for HIV positive MARPs proposed in National
Guidelines for Sex Worker HIV/STI Interventions includes:
• Clinical: HIV care and treatment; STI screening and treatment; TB screening and
referral to treatment; Prevention with Positives; Reproductive health services (FP,
PAC, cervical cancer screening); emergency contraception; PEP; Substance abuse,
assessment and treatment
• Non-Clinical: Psychosocial support; Services to mitigate sexual violence
NOTE: The MARPs TWG intends to expand the guidelines to cover other MARPs
sub-populations (MSMs, IDUs, etc.)
Numerator: 1) Number of newly diagnosed HIV positive MARPS that were offered referral for HIV
care and treatment services to targeted sites during the reporting period
2) Number of newly diagnosed HIV positive MARPS that accessed HIV care and
treatment services through referral at targeted sites during the reporting period
Denominator: None
Disaggregation: By Sex-Male/Female, MARP type-MSM, SW,IDUs, By referral type: offered and
accessed?
Elements: Tested – CSW HV08-11
Tested – IDU HV08-12
Tested – MSM HV08-13
Tested – other MARPs HV08-14
Total MARPS tested for HIV (Sum HV08-11…HV08-14) HV08-15
MARPS tested positive HV08-16
MARPS tested positive and referred for care HV08-17
Denominator: N/A
Purpose: In addition to HIV/STI prevention services, a strong linkage to care and treatment is
vital to meet the needs of MARPs that are diagnosed with HIV. This indicator
measures the scope of MARPs interventions to serve as an entry point to care and
treatment. Existing HIV care and treatment models for the general population may
need adaptation to meet the additional health needs of HIV infected MARPs. Tracking
both in and out referrals is likely to assess effectiveness of linkages and identify barriers
to services for these populations.
Frequency:
Data Source: MOH 711 based on data from daily tally sheets and/or facility registers
Data Management Frontline service provider summarizes the monthly service statistics and fills summary
MOH 711 form and submits to the DHRIO who aggregates the district level statistics
and uploads summary to web-based database which is accessed at central level by HIS
and NASCOP MARP Manager for quarterly program reviews
58
Interpretation: This number provides information on the total number of unduplicated individuals that
were offered referrals for HIV care and treatment sites as well as those who accessed
referral services at targeted sites for MARPS. While it does not explain the quality of
services provided to MARPs upon arrival, it does provide insight to what extent
attempts are made to link HIV-positive MARPs with care and treatment in order to
guide future expansion. May be validated through an inventory of services provided at
targeted sites
59
<Prevention with Positives (PwP)>
Indicator #: Percentage of PLHIVs reached with a minimum package of Prevention with PLHIV
HIV09-01 (PwP) interventions
Programme Goal: Reduce HIV Transmission

Codes: P7.1.D
Definition of The methods for reducing risk for HIV transmission are captured under the
Important Terms: disaggregation as follows:
Disclosed HIV status to sexual partner: Number of newly diagnosed PLHIV who
reported disclosure of HIV status to sexual partner
Partner received on-site HIV testing: Number of people living with HIV (PLHIV)
whose sexual partner/s received on-site HIV testing
On-site screening for STIs/RTI: Number of people living with HIV (PLHIV) who have
received on-site screening for STIs/RTI
Modern contraceptive methods: Number of women LHIV who receive modern
contraceptive methods
Provided with condoms: Number of women LHIV who were provided with condoms
Catchment area: Geographic region from which persons come to receive HIV
prevention services, or from which persons are being recruited into HIV prevention
services. The size and population of this area can vary, depending on organization or
agency and the services provided. For PLHIV, depending on the target sites, there may
be registration available at the local health facility. Alternatively, PLHIV estimates for
subdistricts/districts/regions/the nation can be used if available.
Numerator: Number of PLHIVs reached with a minimum package of Prevention with PLHIV
(PwP) interventions
Denominator: Estimated number of PLHIV [in the catchment area]
Disaggregation: Disaggregate by:
o Disclosed HIV status to sexual partner
o Partner received on-site HIV testing
o On-site screening for STIs/RTI
o Modern contraceptive methods
o Provided with condoms
Elements Disclosed HIV status to sexual partner HV09-01
Partner received on-site HIV testing HV09-02
On-site screening for STIs/RTI HV09-03
Modern contraceptive methods HV09-04
Provided with condoms HV09-05
Denominator:
o None
Purpose: Prevention efforts with HIV positive persons (PwP) are part of a comprehensive
prevention strategy and include both behavioral and biomedical interventions.
The purpose of this indicator is to measure how well clinic/facility-based program of
reaching PLHIV with a minimum package of prevention interventions are performing.
Assessment for STIs and (if indicated) provision of or referral for STI treatment and
partner treatment is part of the package of interventions designed to protect the health
of the infected person and reduce the spread of HIV
Data Collection Data should be collected continuously at the facility level.
Frequency:
60
Data Source: HIV care activity sheet
Data Management The numerator can be generated by counting the number of PLHIV who are reached
Guidelines: with a minimum package of PwP interventions. Minimum Package of PwP
interventions required for the indicator: In order to count under this indicator, PLHIV
must have received at last visit (in a clinic/facility-based or community/home-based
program) the following interventions that constitute the minimum package of PwP:
Assessment of sexual activity and provision of condoms (and lubricant) and risk
reduction counseling (if indicated)
Assessment of partner status and provision of partner testing or referral for partner
testing
Assessment for STIs and (if indicated) provision of or referral for STI treatment and
partner treatment
Assessment of family planning needs and (if indicated) provision of contraception
or safer pregnancy counseling or referral for family planning services
Assessment of adherence and (if indicated) support or referral for adherence
counselling
Assessment of need and (if indicated) refer or enroll PLHIV in community-based
program such as home-based care, support groups, post-test-clubs, etc
that received a minimum package of PwP interventions according to the PwP technical
considerations. The indicator will help teams to determine reach and coverage to help
understand the extent and reach in order to plan for further expansion.
61
<Home &Community-Based HIV Care/HCBC>
Indicator #: Percentage of clients provided with HCBC services in accordance with the national
HIV10-01 guidelines
Programme Goal: Ensuring the provision of quality care for the HIV infected and other chronically ill
people at the home and community level

Codes: 3.2.1
Definition of According to the implementation framework, the comprehensive package of Home and
Important Terms: Community Based Care (HCBC) package includes:
• Clinical and basic nursing care;
• Palliative care, pain relief and symptom management,
• Life skills development;
• Family care and support;
• Food and nutrition support;
• Prevention of HIV transmission;
• Linkage coordination, referral, networking
Potential clients for HCBC services include people with HIV and other chronic or
terminal illnesses, OVC, clinically malnourished individuals, people with special needs
(disabled, nomads, internally displaced, refugees), caregivers and family members of
chronically ill patients
National guidelines = NASCOP’s Implementation Framework for HCBC
Numerator: Number of enrolled clients that received HCBC services during the reporting period
Denominator: Total number of clients that have been enrolled for HCBC (cumulative)
Disaggregation: Disaggregate by age (<15, 15+), Sex; Type of HCBC service (nursing and palliative
care, clinical care with treatment literacy, family care and support, nutrition support,
referrals to health care and support groups)
Elements: HCBC Service – male(<15) HV10-01
HCBC Service – female(15+) HV10-02
HCBC Service – male(<15) HV10-03
HCBC Service – female(<15) HV10-04
Total Provided HCBC (Sum HV10-01…HV10-04) HV10-05
HCBC – Clinical & BNC HV10-06
HCBC – Palliative care HV10-07
HCBC – Life skills development HV10-08
HCBC – Family care and support HV10-09
HCBC – Food and nutrition support HV10-10
HCBC – Prevention of HIV transmission HV10-11
HCBC – Linkage coordination HV10-12
Denominator:
Purpose: It is important to ensure that sick persons and their family are able to access the
minimum level of care at the community. This indicator will measure the coverage
achieved for HCBC to needy sub-groups. It can be used for planning interventions and
allocation of resources for specific HCBC interventions as needed.
Note: Results on Percentage of PLHIVs receiving HCBC and Percentage of PLHIV
receiving nutritional support is needed for reporting to NACC for KNASP III
Data Collection Data collected continuously at facility and community level but aggregated and
Frequency: reported monthly
Data Source: Facility and District HCBC tools aggregated from CHW/CHEW and HCBC desk
diary or registers
62
Data Management CHW/CBO fill HCBC register and submit HCBC summary/tally sheet to HCBC focal
Guidelines: person for respective facility who aggregates statistics and fills the MOH 711 Annex
alias Facility Summary Form for HCBC. The DHRIO aggregates all facility summaries
into the MOH 711 Annex alias the District Summary Form for HCBC. Data uploaded
onto FTP system for HIS and NASCOP to access
Interpretation: This indicator measures the number of clients reached with HCBC services and there is
need to minimize double counting for individuals receiving multiple HCBC services
during the reporting period. The indicator does not give insight on the quality of HCBC
delivered as it is assumed that every service provider will deliver quality care
Note: It may be easier to limit the numerator and denominator to those newly enrolled
during the reporting period as it is difficult to keep track of all clients ever enrolled.
63
Indicator #: Percentage of clients enrolled for HCBC
HIV10-02
Programme Goal Ensuring the provision of quality care for the HIV infected and other chronically ill

Codes:
Definition of According to the implementation framework, the comprehensive package of Home and
Important Terms Community Based Care (HCBC) package includes:
• clinical and basic nursing care;
• Palliative care, pain relief and symptom management,
• Life skills development;
• Family care and support;
• Food and nutrition;
• Prevention of HIV transmission;
• Linkage coordination, referral, networking
Potential clients for HCBC services include people with HIV and other chronic or
terminal illnesses, OVC, clinically malnourished individuals, people with special needs
(disabled, nomads, internally displaced, refugees), caregivers and family members of
chronically ill patients
Although the indicator name may imply all clients, the numerator is limited to those
newly enrolled during the reporting period.
Numerator: Number of clients newly registered for HCBC during the reporting period
Denominator: Number of clients provided with referral to HCBC
Disaggregation: Disaggregate by age, sex and point of referral/entry

Elements Referred for HCBC HV10-13
Newly registered for HCBC HV10-14
Denominator:
Purpose: One of the objectives of the Community Strategy is strengthening of health facility and
community linkages through decentralisation and partnership. This indicator measurs
how many clients that have been referred are able to access HCBC. It can be used to
plan future interventions and to assess the impact of strengthened linkages.
Data Source: CHW/CBO fill HCBC register and submit summary/tally sheet to HCBC focal person
for respective facility who aggregates statistics and fills the MOH 711 Annex alias
Facility Summary Form for HCBC. The DHRIO aggregates all facility summaries into
the MOH 711 Annex alias the District Summary Form for HCBC. Data uploaded onto
FTP system for HIS and NASCOP to access
Data Management HCBC focal person in all facilities aggregates statistics from the CHW monthly tallies
Guidelines: and fills the MOH 711 Annex alias Facility Summary Form for HCBC. The DHRIO
aggregates all facility summaries into the MOH 711 Annex alias the District Summary
Form for HCBC. Data uploaded onto FTP system for HIS and NASCOP to access
Interpretation: This indicator measures the number of new clients who accessed HCBC services during
the reporting period. The indicator does not give insight on the outcome of being
enrolled for HCBC as it is assumed that every client enrolled will receive quality care
64
65
Indicator #: Number of OVC provided with health services
HIV10-03

Codes:
Definition of OVC = a child who is either orphaned, or made more vulnerable because of HIV/
Important Terms: AIDS. An orphan has lost either one or both parents to HIV/AIDS. Vulnerable is HIV-
Positive; lives without adequate adult support (e.g. in a household with chronically ill
parents, a household that has experienced a recent death from chronic illness, a
household headed by a grandparent and/or a household headed by a child); lives
outside of a family care (e.g. in a residential care or on the streets); or is marginalised,
stigmatised or discriminated against.
Health services may be provided directly by the CHEW/CHW or via outreach. May
include HIV prevention, treatment, follow up care, nutritional support or linkage to
support group. Also includes health care referral
Numerator: Number of OVC that received health care during the reporting period
Denominator: N/A
Disaggregation: Disaggregate by age and sex
Elements:
OVC (<18 years) provided service HV10-15
Denominator:
Purpose: OVCs are at an increased risk of suffering psychological distress, economic hardships,
exploitation, and trafficking and of HIV infection. Girls in the developing world in
particular often face special vulnerability to the HIV/AIDS pandemic and its effects.
This indicator measures how many OVCs have access to essential health services either
directly or indirectly through a CHW/CHEW or HCBC focal person at a health
facility. Results from this indicator provide information about the extent that OVCs are
accessing health services and where gaps may exist. It can be used to plan OVC
interventions and allocation of resources.
Data Source: Data captured in HCBC client registers by the CHW or CBO will be channelled
upward to facility focal points who will aggregate into a facility HCBC summary form
and then submit to the divisional HCBC Coordinator who will forward to a District
HCBC coordinator who will compile district data for onward flow to the provincial
HCBC Coordinator who in collaboration with the PASCO will compile data for
onward flow to NASCOP who will work closely with the NACC regional
representative to analyse all provincial reports to produce a national HCBC summary.
Interpretation: This indicator measures the number of OVCs that access health care through HCBC
providers during the reporting period. The indicator does not give insight on the quality
of health care provided as it is assumed that provider is mandated to deliver quality care
66
Indicator #:
HIV10-04 Number of HCBC commodities distributed

Codes:
Definition of HCBC Commodities = HCBC kits and the Basic Care Package
Important Terms: HCBC kits often issued by supplies stores to CHWs or focal person at facilities who
uses for delivery of clinical and home based care services;
BCP issued by the CHWs or facility desk to PLHIV for self-use
Numerator:
Number of HCBC commodities distributed during the reporting period
Denominator: N/A
Disaggregation: By type of commodity: HCBC Kit or Basic Care Package
By recipient: CHW/CHEW; volunteers; PLHIV; HCBC focal person/desk at facility
By distribution level: either received from supplier or issued to consumer
Elements:
HCBC Kits – CHW/CHEW HV10-16
HCBC Kits – Volunteer HV10-17
HCBC Kits – Focal/Desk HV10-18
BC Package – PLHV HV10-19
Denominator:
Purpose: A reliable supply of home care kits is vital for ongoing delivery of HCBC. This indicator
measures the flow of commodities. This indicator measures the supply of HCBC
commodities. As efforts are made to scale up HCBC it is important to ensure kits and
the BCP is available for those who need them and any stock-outs may have a direct
effect on uptake of HCBC services.
Data Source: CHW/CBO fill HCBC register and submit summary/tally sheet to HCBC focal person
for respective facility who aggregates statistics and fills the MOH 711 Annex alias
Interpretation: This indicator measures the amount of HCBC commodities provided during the
reporting period. However, it does not give information on the quality or timeliness of
the distribution. Simply monitoring supplies could be misleading since a facility may
have buffer stocks that are sufficient to cover gaps during stock-outs. Monitoring the
distribution trends over time may provide a better understanding of the demand for
HCBC commodities
Indicator #:
HIV10-05 Number of deaths at the community level
67

Codes:
Definition of Deaths due to all causes

Important Terms:
Numerator: Number of reported deaths at the community level
Denominator: N/A
Disaggregation: By sex, age groups (<15, 15+)
Elements: Death – community – male (<15) HV10-20
Death – community – female (<15) HV10-21
Death – community – male (15+) HV10-22
Death – community – female (15+) HV10-23
Total Deaths Community (Sum HV10-20…HV23) HV10-24
Denominator: N/A
Purpose: Majority of deaths occur at the community level and do not get reported. This indicator
will track the number of deaths and over time possibly document at the local level what
is the likely cause of death via verbal autopsy.
Data Source: Facility and District HCBC tools aggregated from CHW/CHEW and HCBC desk tally
diaries or CBO registers
Data Management CHW/CBO fill HCBC register and submit summary/tally sheet to HCBC focal person
Guidelines: for respective facility who aggregates statistics and fills the MOH 711 Annex alias
Interpretation: By mapping where the deaths are occurring, it may be possible to identify high risk
areas and root causes. This data needs to be verified through observation of the funeral
or new grave-site. Tracking this indicator over time will help to determine the frequency
of death but not the emergency actions taken e.g. prior to death nor support given to the
bereaved family.
68
Indicator #:
Number of eligible clients who received food and/or nutrition support.
HIV10-06
Programme Goal: Improving food security and/or nutrition services among eligible clients

Codes C5.1.D
Definition of Nutritional Support: refers to and includes the following food and/or nutrition services:
Important Terms: Supplemental food support for nutritionally vulnerable children (OVC)
Therapeutic and supplementary food for clinically malnourished orphans and
vulnerable children whose HIV status is negative or unknown.
Supplemental food support for nutritionally vulnerable PMTCT clients
Micronutrient supplements
Nutrition counseling
Promotion of optimal infant and young child feeding
Services to improve food security
School and after-care feeding
Household and community gardens
Numerator: Number of clients who received food and/or nutrition services during the reporting
period.
Denominator: N/A
Disaggregation: Age: <18, 18+, Pregnant/lactating women

Elements: Clinically malnourished (<15) HV10-25
Clinically malnourished (15+) HV10-26
Total malnourished (Sum HV10-25…HV10-26 HV10-27
Nutritional support (<15) HV10-28
Nutritional support (15+) HV10-29
Total Nutritional support (Sum HV10-28…HV10-29 HV10-30
Received food/nutrition support (<18) HV10-31
Received food/nutrition support (18+) HV10-32
Nutrition support - pregnant/lactating women HV10-33
Denominator: N/A
Purpose: This indicator measures how many clients receive supplemental food, food security
support and/or nutrition services, including therapeutic or supplementary food for
OVC whose HIV status is negative or unknown. Results from the indicator provide
information about the extent that food support is reaching vulnerable clients and where
gaps may exist. It can be used to plan interventions and allocation of resources for food
and nutrition.
Data Collection Data should be collected continuously at the facility level (or community level) and
Frequency: aggregated at the end of the reporting period.
Data Source: Records that document provision of food support to clients.
Data Management The numerator can be generated by counting the total number of clients who received
Guidelines: food supplementation and/or nutrition services during the reporting period. Clients that
receive food supplementation and/or nutrition services more than once during the
reporting period should only be counted one time.
Interpretation: It is important to note that the indicator includes a variety of types of food support,
including supplemental feeding, addressing food insecurity among PMTCT women and
OVC, and other food related services. These are distinct food interventions with distinct
objectives, and the total indicator does not provide information about coverage of each
individually.
69
70
<System Support and Governance>
Indicator #: Number of facilities with laboratories having capacity to perform clinical laboratory
HIV11-04 tests
Programme Goal: Improve laboratory capacity

Codes: H1.1.D
Definition of Clinical laboratory: refers to laboratory that has the capacity (i.e. infrastructure,
Important Terms: dedicated lab personnel, and equipment) to:
Perform testing for the diagnosis of HIV infection with either rapid test, EIA or
molecular methods; and,
Perform clinical laboratory tests in any of the following areas: hematology, clinical
chemistry, serology, microbiology, HIV/AIDS care and treatment monitoring with
CD4 testing or HIV viral loads, TB diagnostic and identification, malaria infection
diagnosis, and OI diagnosis.
Numerator: Number of facilities with laboratories having capacity to perform ART monitoring
through clinical laboratory test
Denominator: N/A
Reportable Data Numerator: N/A
Elements: Denominator: N/A
Purpose: An important component for clinical care is laboratory services. An adequate number
of clinical laboratories are needed to perform testing for HIV/AIDS diagnostics, and
care and treatment services. This indicator serves as a proxy for measuring coverage of
HIV/AIDS patient monitoring testing. Knowing the number of HIV/AIDS clinical
laboratories can indicate if testing coverage is adequate or if more capable laboratories
are needed.
Data Collection Annually
Frequency:
Data Source: Assessment reports and master facility list
Data Management A clinical laboratory is counted if it meets the criteria of having the capacity, with
Guidelines: infrastructure, personnel, and equipment, or is performing testing for the diagnosis of
HIV infection with either rapid test, EIA or molecular methods and is performing other
clinical laboratory tests in either of the following areas: hematology, clinical chemistry,
serology, microbiology, HIV/AIDS care and treatment monitoring with CD4 testing or
HIV viral loads, TB diagnostic and identification, malaria infection diagnosis, and OI
diagnosis.
A clinical laboratory can be a physical or mobile structure and must have dedicated
laboratory personnel. A facility that does testing for only HIV rapid test diagnosis, such
as a VCT or PMTCT site, should not be counted.
The laboratory infrastructure will determine a laboratory’s capacity to do serology,
hematology, microbiology, clinical chemistry, and CD4 testing.
All laboratories that meet the minimum definition of being capable of or actually
performing HIV diagnostic *and* patient monitoring tests should be counted regardless
of tiered capacity.
Interpretation: This indicator, because of different capacities of laboratories, does not measure
adequacy of coverage of laboratory services, but will give indication of trends in
delivering laboratory services. It should be noted, laboratories at the higher level will
have greater capacity for testing than those at a lower levels. This indicator also does
not attempt to measure the quality, cost, and effectiveness of services provided.
71
Indicator #: Percentage of testing facilities (laboratories) that are accredited according to national or
HIV11-05 international standards
Programme Goal: Improve laboratory capacity

Codes: H1.2.D
Definition of Accreditation: provides documentation that the laboratory has the capability and the
Important Terms: capacity to detect, identify, and promptly report all diseases of public health
significance that may be present in clinical and research specimens. The accreditation
process further provides a learning opportunity, a pathway for continuous
improvement, a mechanism for identifying resource and training needs, and a measure
of progress.
Numerator: Number of health facilities meeting accreditation standards
Denominator: Total number of health facilities


Purpose: Laboratory services are an essential component in the diagnosis and treatment of
persons infected with the human immunodeficiency virus (HIV), and other related
diseases of public health significance, including malaria and TB. Presently, the
laboratory infrastructure for HIV, malaria, and TB testing and quality assurance
remains weak. There is therefore an urgent need to strengthen the laboratory. The
establishment of accreditation systems will help to improve and strengthen the capacity
of their laboratories.
Frequency:
Data Management A clinical laboratory is counted as being accredited if it has received national or
Guidelines: international accreditation that meets the World Health Organization (WHO)
Accreditation of Public Health Laboratory Networks standard.
Full accreditation and levels of accreditation are assessed by a standardized set of

criteria defined by WHO Accreditation of National Laboratory Systems or other
acceptable international and national standards. Full accreditation is defined by
meeting acceptable criteria in order to receive certification by a recognized and WHO
approved accreditation organizations. Accreditation certificates are a formal
recognition that a laboratory is competent to perform clinical testing.
Interpretation: Determining the number of accredited clinical laboratories, the progress of a laboratory
towards accreditation, and the laboratory’s ability to maintain accreditation over time
provides documentation that the laboratory has the capability and the capacity to
perform quality-assured clinical laboratory testing for HIV diagnostic and care and
treatment services. Maintaining accreditation is a continuous process and can serve as
a measure of sustainability of quality laboratory service.
72
Indicator #: Percentage of health facilities providing nutritional commodities
HIV11-06
Programme Goal: The goal of the nutrition support is to improve nutrition, health, quality of life and
duration of survival of individuals.

Codes:
Definition of Nutritional care and support includes many components, such as:
Important Terms: • nutrition education and counselling in health facilities;
• water, hygiene and food safety interventions to prevent diarrhoea; adequate
quality/quantity of food and food aid.
Nutrition support refers to intravenous nutrition or orally modified for-mulas
necessitated by inability to consume a general diet; administered to malnourished
individuals who cannot consume food in its original form.
Numerator: Number of health facilities providing nutritional commodities
(FBP, CSB, F75, F100, RUTF, MM)
Denominator: Total number of health facilities
Reportable Data N/A

Elements
Purpose: • Nutrition and HIV are strongly related to each other. A person with HIV
infection is more at risk for malnutrition for reasons such as reduced food
intake, poor absorption, changes in metabolism, chronic infections and
illnesses, anorexia, diarrhoea, fever, nausea, oral and oesophageal infections,
and anaemia. The management of those conditions and the provision of
nutritional support are effective interventions that are fundamental to other
HIV/AIDS care activities.
• Good nutrition may result in increased resistance to infection and disease,
improved energy and a person who is stronger and more productive.
• Antiretroviral therapy should often be taken together with good nutrition and
safe water, making access to adequate food important to effective treatment.
• HIV infection has a significant impact on nutrition at the level of the family
and community, as well. In places where HIV seroprevalence is high, food
insecurity is often high as well.
Frequency:
Data Management National programme records of health facilities providing nutritional commodities.
Guidelines:
Interpretation: Results from this indicator provide information about the accessibility of food and
nutrition support for individuals that need it. The indicator provides information about
coverage, but not about the duration of food support provided to clients, drop-out rates,
quality of the foods, or existence of complementary interventions with the food.
73
Indicator #: Percentage of health facilities that provide virological testing services for infant
HIV11-02 diagnosis for HIV exposed infants, on site or through DBS network
Programme Goal: Increase access to early infant diagnosis

Codes: C4.3.N
Definition of Dried blood spot testing (DBS): is a method of screening for HIV infection and other
Important Terms: conditions using DNA amplification.
Numerator: Number of PMTCT sites offering virological testing services.

Denominator: Total no of PMTCT sites
Reportable Data Numerator:N/A

Elements Denominator: N/A
Purpose: Early infant diagnosis of HIV through on-site virological testing or through dried blood
spot (DBS) is a critical tool to identify HIV-infected infants for immediate referral into
care and treatment, and to facilitate decision-making for health providers. This
indicator measures the extent of scaled-up and increased access to early infant diagnosis
of HIV for infants born to HIV-infected women.
Frequency:
Data Source: Programme reports and Master Facility List
Data Management Virological testing is only performed at a national reference laboratory, or sent out of
Guidelines: country, due to the cost of buying virological testing machines. Thus, provision of
virological testing refers to on-site testing, as well as transport of DBS filter papers to a
virological testing laboratory. A site that physically refers a mother and her infant to a
site that provides virological testing on-site or through DBS is not included in the
numerator.
Interpretation: This indicator measures only provision of virological testing through on-site testing or
use of DBS. It does not measure the quality of the virological testing or the system in
place (e.g. delays in reporting of results, stock-outs of DBS or virological testing
reagents and other bottlenecks in the system).
74
Indicator #:
HIV11-03 Percentage of health facilities providing a package of PMTCT services
Programme Goal: To increase access to PMTCT services

Codes: 4.0.2 P1.3.D
Definition of ‘ANC facility’ is any health facility that provides Antenatal Clinic services.
Important Terms:
‘On-site’ refers to a service being offered within a health facility structure or compound.
PMTCT services that are offered in separate service units but within the same health
facility (e.g HIV testing in the ANC and ARVs for PMTCT in the HIV care and
treatment unit are considered to be ‘on-site’. Where blood samples are sent out for HIV
testing [e.g. to a national reference laboratory or health facility], this is also considered
‘on-site’).
Numerator: Numerator: Number of health facilities providing ANC services that provide both HIV
testing and ARVs for PMTCT on site
Denominator: Denominator: total number of facilities offering ANC services
Purpose: On-site availability is important to help reduce loss-to-follow-up of HIV-infected
pregnant women and exposed infants. This indicator measures the on site availability of
HIV testing and ARVs for PMTCT at all health facilities that provide ANC services.
While PMTCT programmes comprise several other interventions that are also
important for preventing mother-to-child transmission, these two intervention areas
were chosen based on the importance of the following:
• availability of HIV testing in ANC to identify pregnant women who are infected
with HIV and in need of PMTCT services;
• availability of and increased access to ARVs for HIV-infected pregnant women for
the prevention of mother-to-child transmission
Data Collection
Frequency: Annually
Data Source: Master Facility List
Data Management Numerator: National programme records of health facilities providing HIV testing
Guidelines: services and ARVs for PMTCT.
Denominator: National programme records of lists of health facilities providing ANC
services.
Interpretation: This indicator is used to count facilities that provide HIV testing and ARVs for PMTCT
only in the ANC and/or L&D sites among ANC (or L&D) facilities providing HIV
testing. This indicator allows for monitoring the availability of and improved access to
HIV testing and ARVs for PMTCT. It does not, however, measure other interventions
(e.g. family planning, ART eligibility assessment), which are also critical for effective
PMTCT. The indicator does not capture the quality of ARV and HIV testing services
provided.
75
Indicator #:
HIV11-07 Number of health facilities that offer ART services
Programme Goal: To increase access to ART services

Codes: 4.0.1 UA-G1 T1.5.D HIV-T2
Definition of A service outlet refers to the lowest level of service. For example, with regard to
Important Terms: clinical activities, the lowest level for which data exists should be a service outlet such
as a hospital, clinic, or mobile unit. ART services refer to activities including the
provision of antiretroviral drugs and clinical monitoring for antiretroviral therapy
among those with HIV infection.
ART refers to long-term combination antiretroviral therapy intended primarily to
improve the health of the individual on treatment, not to prevent mother-to-child
transmission.
Numerator: Number of health facilities that offer ART services
Denominator: N/A
Disaggregation: By type of site: Public, Private, NGO
Purpose: This indicator measures the progress of a program to expand the number of locations in
which ART services are delivered in accordance with national or international
standards.
Data Collection
Frequency: Annual
Data Source: Facility ART registers/databases; health facility census; Program monitoring tools
Data Management Count all service outlets providing ART including designated PMTCT+ sites.
Guidelines: The indicator is calculated by summing of the number of facilities reporting availability
of ART services. Information on the availability of specific services should be kept at
the national or province and district levels. The national level should regularly update
their programme records on health facilities offering ART services.
Interpretation: This indicator does not describe the geographic location or distribution of service
outlets. This indicator does not consider the quality of service provision, which would
require more in-depth evaluation efforts like facility surveys. This is not a complete
measure of coverage, as there is no denominator of total facilities.
76
Indicator #:
HIV11-08 Percentage of TB treatment facilities that offer ART services
Programme Goal: To increase access to ART services for TB patients who are HIV positive

Codes: 4.0.1 UA-G1 T1.5.D HIV-T2
Definition of A service outlet refers to the lowest level of service. For example, with regard to
Important Terms: clinical activities, the lowest level for which data exists should be a service outlet such
as a hospital, clinic, or mobile unit. ART services refer to activities including the
provision of antiretroviral drugs and clinical monitoring for antiretroviral therapy
among those with HIV infection.
ART refers to long-term combination antiretroviral therapy intended primarily to
improve the health of the individual on treatment, not to prevent mother-to-child
transmission.
Numerator: Number of TB treatment facilities that offer ART services
Denominator: Total number of TB treatment facilities
Disaggregation: By type of site: Public, Private, NGO
Purpose: This indicator measures the progress of TB/HIV program integration. This indicator
measures the degree to which TB treatment facilities have increased the care offered to
HIV-positive TB patients.
Data Collection
Frequency: Annual
Data Source: health facility census; Program monitoring tools
Data Management Count all TB treatment service outlets providing ART. The indicator is calculated by
Guidelines: summing of the number of facilities reporting availability of ART services. The national
level should regularly update their programme records on health facilities offering ART
services.
Interpretation: This indicator does not describe the geographic location or distribution of service
outlets. This indicator does not consider the quality of service provision, which would
require more in-depth evaluation efforts like facility surveys.
77
Indicator #: Percentage of health care facilities that have the capacity to provide post-exposure
HIV11-09 prophylaxis
Programme Goal: Improve availability and accessibility of PEP services

Codes: 2.5.1 UA-B2 P6.2.N HIV-P15
Definition of This area assesses the percentage of facilities in which postexposure prophylaxis is
Important Terms: provided and all items to support the service are available, including written protocols
and guidelines, a recordkeeping and monitoring system, availability of antiretroviral
drugs for postexposure prophylaxis and special storage. A facility may also refer for
postexposure prophylaxis but should have available a system to follow up and monitor
their employees to be considered as supporting the service.
Data collection Each point-of-service area for HIV/AIDS curative care in a facility
must have all the individual items and analysis in the checklist below to meet the
requirements for this area.
Numerator: Number of facilities that have individuals items for providing postexposure prophylaxis
Denominator: Total number of health facilities surveyed
Purpose: This indicator measures the availability of post-exposure prophylaxis services.
Data Collection Annual
Frequency:
Data Source: This information should be collected through a health facility survey
Data Management Facilities offering post-exposure prophylaxis
Guidelines: An observed written protocol for postexposure prophylaxis in the service area
where postexposure prophylaxis is offered
A register or record indicating postexposure prophylaxis services are provided
A system to monitor clients receiving postexposure prophylaxis for full compliance
with the regimen
Country-specific postexposure prophylaxis antiretroviral drugs available the day of
the survey
Antiretroviral drugs for postexposure prophylaxis kept in a locked storage unit
separate from other HIV/AIDS antiretroviral combination therapy services and
maintained solely for postexposure prophylaxis
Interpretation: This indicator examines post-exposure prophylaxis services among all health facilities.
This indicator does not intend to capture the type and quality of PEP services provided.
PEP services may include first AID, counselling, testing, provision of ARVs, medical
care, trauma counselling, linkages with police, and other follow-up and support. Simple
monitoring of PEP availability through program records does not ensure that all PEP-
related services are adequately provided to those who need them. Although this
indicator does not stratify by level of health care facility, managers of the HIV/AIDS
programs can analyze this information if desired.
78
Indicator #: Percentage of HIV testing and counselling sites with quality assurance (QA) systems for
HIV11-01 HTC services – via periodic monitoring e.g. annual proficiency testing
Programme Goal: Improve quality of HIV testing and counseling services

Codes: P11.5.N
Definition of “Quality assurance assessments” include one or more of the following:

Important Terms: o Exit interviews, supervisory observations, refresher trainings, and support
supervision.
The following additional questions may be asked if time and resources allow:
o Which QA systems are used?
If a health facility survey is being conducted for other reasons then:
o Are client satisfaction interviews conducted?
o How has the site used QA data to make changes to HTC services?
Numerator:
Number of sites providing HIV testing and counselling services with a QA system
Denominator: Total number of HTC sites Systems are needed to ensure that all persons tested
give consent and are provided with their test results and high quality counselling.
Purpose: Systems are needed to ensure that all persons tested give consent and are provided with
their test results and high quality counselling.
Data Collection
Frequency: Annually
Data Source: Review of facilities
Data Management Review of facilities to check whether the following is in place:
Guidelines: o Policies, guidelines and/or standard operating procedure (SOP) for QA are in
available in the testing and counselling sites;
o Record of current registration and/or licensing systems for the facility is
present at the facility and accessible to site reviewers;
o Proficiency testing which includes QA completed by all persons at a site
involved in conducting HIV counselling(QA includes observation of new
trainees; supportive counselling supervision of all staff);
o District managers should report:
a) How many sites report QA results;
b) How many sites conduct measures to assess quality of interactions
such as client satisfaction interviews, etc?
Interpretation: Strengths: This indicator will help assess the implementation and use of QA systems. It
will help ensure that HTC services are satisfactory to clients and in line with
international standards on counseling ethics.
Limitations: A national or site specific QA system may be in place but not regularly
utilized. Understanding what QA means varies widely with respect to counseling as this
is a private encounter between the counsellor and the person receiving services. This
indicator does not assess if feedback from the assessment is addressed. Quality
assurance systems are only effective if findings and recommendations are implemented.
79
Indicator #: Proportion of health facilities receiving at least 80% of their blood supply from NBTS
HIV11-10 network
Programme Goal: To improve safety and availability of blood supply

Codes: P2.3.N
Definition of National blood transfusion services: The provision of safe and adequate blood is the
Important Terms: responsibility of Government of Kenya. The formation of the nationally organized and
managed blood programme is an integral part of the Governments national health care
policy and health care infrastructure. The National Blood Transfusion Services (NBTS)
was established in accordance with the National Blood Policy and is responsible for
establishing and maintaining a national quality system, including the development of
guidelines and standards, staff training, a data/ information management system and a
system for monitoring and evaluation of all the blood transfusion activities in the
country.
Numerator: Number of all transfusing health facilities receiving at least 80 Percentage of blood
supply from NBTS
Denominator: Number transfusing health facilities
Purpose: A well-coordinated national blood transfusion service (NBTS) is a source of safe blood.
This indicator will measure trends in the use of NBTS network blood by health facilities
which perform transfusions. The objective is to create a single quality-assured national
blood supply, with no blood collected or distributed outside of the NBTS network. This
indicator will track progress in expanding the coverage of NBTS-supplied safe blood to
facilities which perform blood transfusions.
Data Collection Data on the number of hospitals performing blood transfusions and the number of these
Frequency: hospitals which receive at least 80% of their blood from the NBTS will be updated
quarterly by the NBTS through the routine programmatic monitoring process.
Data Source: The Blood Safety Indicator System (BSIS), a Web-based data collection tool developed
by HHS/CDC and the Georgia Institute of Technology. NBTS will enter the number of
health facilities which are accredited by the government to perform blood transfusions
into the BSIS on a quarterly basis. The BSIS will automatically aggregate these data at
the end of each year. Likewise, NBTS will use the BSIS to enter the number of hospitals
performing transfusions which receive at least 80% of their blood from the NBTS. The
amount of NBTS blood delivered to each health facility will be drawn from NBTS logs
on the issuance of blood from NBTS network blood banks to accredited hospitals.
Data Management The number of hospitals receiving at least 80% of the blood units used for transfusion
Guidelines: from the NBTS network: The NBTS tracks the distribution of blood from blood banks
and blood depots in the NBTS network. Blood bank data systems will report the
number of units issued to each hospital. This will serve as the numerator to calculate
whether the hospital has received at least 80% of its blood from the NBTS. The
denominator for this proportion will be derived from information on the total number
of units transfused annually by each hospital.
Interpretation: This indicator is designed to measure the National Blood Transfusion Service’s progress
toward increasing the use of blood that has been collected from low-risk donors and
tested by a quality-assured laboratory for four major TTI.
80
Indicator #: Number of individuals who successfully completed in-service training on HIV/STI
HIV11-11 interventions for MARPs
Programme Goal: Availability of trained service providers to offer all packages of HIV/STI services to
MARPs (Basic, Clinical, Non-Clinical and Enabling Environment)
Increased access to HIV/STI interventions for MARPs

Codes: H2.3.D
2) National guidelines for HIV/STI interventions for Sex Workers proposes 4
intervention packages: Basic, Clinical, Non-Clinical and Enabling Environment which
comprises of several components e.g. as summarized below:
It is assumed that the training will be tailored according to the proposed packages.
NOTE: The MARPs TWG intends to expand these guidelines for application to other
MARPs groups as needed
3) Methods of in-service training: continuing education, on the job training, computer
based training with or without a short term practicum prior to certification
4) Types of Individual: may include clinical and non-clinical staff depending on the
package e.g. community health workers, Peer Educators for Basic; nurses, doctors,
clinical officers, counselors, nutritionist, pharmacist for Clinical.
5) MARPs- Most At Risk populations are those populations with a concentration of risk
behaviors.
Numerator: A count of the number of individuals who completed the standard course on HIV/STI
interventions for MARPs as per the national curriculum during the reporting period
Denominator: None
Disaggregation: By cadre: clinical (doctors, nurses, clinical officers, midwives) and non-clinical
(program staff, peer educators)
By sex: Male, female; by location
Reportable Data o Numerator: N/A
Elements: o Denominator: N/A
Purpose: Help the program assess the coverage, scale-up and accessibility of services to MARPs
Data Collection Collect monthly and report quarterly
Frequency:
Data Source: COBPAR or NASCOP Quarterly activity form draws data from certification list for
completed training courses
Data Management Training coordinator submits certification list to Program coordinator who fills
Guidelines: quarterly activity form and submits to the DASCO and CACC coordinators by 5th of
81
month; Aggregated summary forms for district or constituency submitted to Field
Coordinator and PASCOs by 15th of month for aggregation of regional data then
forwarded to the central NASCOP and NACC by 20th of month
Interpretation: This indicator will reveal the training capacity as well as the number and distribution of
additional workers that are available for delivery of HIV/STI services for MARPs at
targeted sites. Training is one of the strategies for scaling up MARP-friendly sites.
However, this indicator does not measure the quality of the training nor outcomes of
training in terms of competencies and job performance. It also does not measure the
retention of workers.
82
Indicator #: Number of targeted outlets that offer HIV/STI services for MARPs
HIV11-12
sexual partners

Codes:
2) Targeted outlet is any fixed site identified and/or registered as an intervention site for
MARPs within the NASCOP database or Master Facility List or newly targeted due to
its location in MARPs hot spots. May include a health facility, VCT site, entertainment
establishments, drop in centres, NGO program office
3) Services may comprise of all or selected components from the Basic, Clinical, Non-
Clinical or Enabling Environment Packages
and skills building; demonstration and supply of condoms and lubricants and
4) MARPs friendly – tailored service provision i.e. culturally competent services which
are responsive to the needs of the sub-population (non-judgmental, non-stigmatizing,
adequate [sufficient number of trained counselors, adequate commodities] free or
affordable accessible [effective client flow, reduction in # of logistical barrier, client-
driven delivery of services]
Numerator: Number of targeted outlets providing HIV/STI services for MARPs as per minimum
standards (to be defined in the near future)
Universal Access indicator: Number of targeted service delivery points for sex workers where STI
services are provided per 1000 sex workers
Number of needle and syringe programme (NSP) sites per 1000 injecting drug user
Denominator: None
Disaggregation: By type of MARP; By type of site: Public/private/NGO; by type of services for
MARPs (e.g. condom outlet, STI clinic, HTC, Post-Rape Care)
Purpose: Reducing HIV prevalence among MARPs and thereby the general population can only
be achieved if there is good coverage of HIV/STI services for MARPs. This indicator
measures the availability of HIV/STI services for MARPs. The strategy of the HIV/STI
guidelines is to scale up the number of MARP-friendly sites in stand-alone sites as well
as existing health facilities in MARPs hot spot areas. These types of sites are only
effective if the owners are recognized and supportive of HIV/STI interventions for
MARPs.
Data Collection Collect and report annually
Frequency:
Data Source: Annual program mapping for MARP-friendly services based on review of MOH 711
and COBPAR reporting sites plus formal annual partner reports and field visits; every
2-3 years for facility surveys
83
Data Management Program coordinator-CACC/DASCO collect reports from implementing partners for
Guidelines: MARPs interventions; Submit copies of report to NASCOP MARP Program Manager
for service availability mapping. Also send copy to the Division of HIS focal point for
updating of web-based Master Facility List. Validation through quarterly field visits.
Interpretation: This indicator provides information about the availability of clinical and non-clinical
HIV/STI services for MARPs in targeted locations, but it does not capture information
about the quality of services provided. HIV/STI interventions should ideally be
delivered as a comprehensive package of services. Simply counting the sites will not
ensure the delivery of complete packages needed by MARPs. Nevertheless, mapping
new sites initiating services in MARPs hot spot areas over time will inform the
improvement in access and inform planning for future expansion in MARPs services
84
Indicator #: Percentage health facilities linked with community units
HIV11-13
Programme Goal Ensuring the provision of quality care for the HIV infected and other chronically ill

Codes:
Definition of Linkage with community refers to the presence of CHEW/CHW or focal person/desk
Important Terms for HCBC services
Numerator: Number of health facilities with CHEW/CHW or focal HCBC person/desk providing
linkage with the community
Denominator: Number of facilities

Purpose: Proper linkages of home and community based care programmes and health facilities
need to be established through focal points at health facility who maintain lists of all
CHWs and CBOs involved with HCBC. This indicator measures the proportion of
health facilities with focal person/unit referred to as ‘desk’ that have links with CHWs or
CBOs. Although the unavailability of the links should not be a barrier to delivery of
HCBC services, the HCBC implementation framework recommends that such links will
facilitate better HCBC service delivery. Tracking this indicator is important as any
decisions to extend or expand the available HCBC services or improve the quality of care
will depend on the existence of these links.
Data Collection Data collected continuously at facility and community level but aggregated and reported
Frequency: monthly
Data Source: Data captured in HCBC client registers by the CHW or CBO will be channelled upward
to facility focal points who will aggregate into a facility HCBC summary form and then
submit to the divisional HCBC Coordinator who will forward to a District HCBC
coordinator who will compile district data for onward flow to the provincial HCBC
Coordinator who in collaboration with the PASCO will compile data for onward flow to
NASCOP who will work closely with the NACC regional representative to analyse all
provincial reports to produce a national HCBC summary.
Data HCBC focal person in all facilities aggregates statistics from the CHW monthly tallies
Management and fills the MOH 711 Annex alias Facility Summary Form for HCBC. The DHRIO
Guidelines: aggregates all facility summaries into the MOH 711 Annex alias the District Summary
Interpretation: This indicator measures the existence of CHEWs/CHWs or focal HCBC desks at
targeted health facilities during the reporting period. In addition to not informing the
quality or strengths of those identified links, it also does not give information on the
direct links from the community level to the health facilities.
85

Nascop Indicators Manual

Uploaded by

Copyright:

Available Formats

Nascop Indicators Manual

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Nascop Indicators Manual

Uploaded by

Copyright:

Available Formats

NASCOP

The general purpose of an Indicator Description Template is to:

How to use this Manual

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Definition of Receiving Cotrimoxazole: Individuals should be considered to be “receiving”

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

CURRENT on ART: Refers to the number of patients currently on ART at a given

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

For details on procedures, refer to the “Kenyan Guidelines on Nutrition and

Indicator #: Percentage of ART clients with improved nutrition status

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Definition of Mother-to-child transmission (MTCT): is when an HIV-infected woman passes the

Two methods for calculating the numerator can be used:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Denominator: Denominator: All exposed infants at 6 months and 12 months

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Three methods for calculating the denominator can be considered:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Numerator: No of HIV exposed infants confirmed positive.

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Definition of ABC strategy: refers to "population-specific interventions" that emphasise:

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other

Reportable Data Numerator:

Referees: KNASP UNGASS AOP WHO UNICEF PEPFAR GFTAM Other